Wei-Lien Wang, M.D.

Peer-Reviewed Articles

1. Valenzuela Perez, RF, Duran Sierra, EJ, Antony, M, Amini, B, Lo, S, Torres, KE, Benjamin, RS, Ma, J, Hwang, K, Stafford, RJ, Araujo, DM, Bishop, AJ, Ratan, R, Wang, W, Espinoza, J, Valenzuela, PV, Wu, C, Madewell, JE, Murphy Jr, WA, Costelloe, C. Building a pre-surgical multiparametric-MRI-based morphologic, qualitative, semiquantitative, first and high-order radiomic predictive treatment response model for undifferentiated pleomorphic sarcoma to replace RECIST. Cancer Imaging 25(1), 2025. e-Pub 2025. PMID: 40281609.
2. Parisi, X, Ghosh, A, Wang, W, Cortes-Santiago, N, Medeiros, LJ. Late Recurrence of Spindle Cell Sarcoma in Association with TPM3::NTRK1 Fusion. International Journal of Surgical Pathology 33(8):1709-1712, 2025. e-Pub 2025. PMID: 40491214.
3. Msaouel, P, Tannir, NM, Meric-Bernstam, F, King, JM, Voss, MH, Cheng, JP, Thomas, SS, Lim, ZD, Karki, M, He, R, Genovese, G, Sheth, RA, Ingram, D, Shamsutdinova, D, Wani, K, Wang, W, Lazar, A, Knipper-Davis, D, Berlinski, A, Soares, T, Stupichev, D, Kryukov, K, Davitavyan, S, Novokreshchenova, A, Lebedev, D, Kurpe, S, Kravets, A, Belousov, D, Hensley, M, Bagaev, A, Paradiso, F, Kushnarev, V. Identification of therapeutic targets for renal medullary carcinoma via integrated genomic and transcriptomic profiling. Cell Reports Medicine 6(11), 2025. e-Pub 2025. PMID: 41172996.
4. Traweek, R, Zoghbi, M, Segura Lazcano, R, Cope, B, Bishop, AJ, Farooqi, AS, Mitra, D, Yoder, A, Guadagnolo, BA, Ingram, D, Wani, K, Shamsutdinova, D, Lazar, A, Wang, W, Scally, CP, Keung, EZ, Torres, KE, Hunt, KK, Ratan, R, Livingston, JA, Nakazawa, MS, Araujo, DM, Patel, S, Ravi, V, Conley, AP, Zarzour, MA, Somaiah, N, Roland, CL, Nassif, EF. Hyalinization-based pathologic response and immune infiltration following neoadjuvant radiotherapy with or without immune-checkpoint blockade in localized undifferentiated pleomorphic sarcoma. ESMO Open 10(7), 2025. e-Pub 2025. PMID: 40561658.
5. Grimm SL, Karki M, Blum KA, Bertocchio JP, He R, Tripathi DN, Zacharias NM, Lebenthal JM, Sheth RA, Rao P, Genovese G, Lu Z, Bast RC, Ingram DR, Lazcano R, Wani KM, Wang WL, Lazar AJ, Tannir NM, Walker CL, Coarfa C, Msaouel P. CA-125 as a Biomarker in Renal Medullary Carcinoma: Integrated Molecular Profiling, Functional Characterization, and Prospective Clinical Validation. Clin Cancer Res 31(6):1057-1068, 2025. e-Pub 2025. PMID: 39836407.
6. Valenzuela Perez, RF, Duran Sierra, EJ, Canjirathinkal, M, Amini, B, Hwang, KP, Ma, J, Torres, KE, Stafford, RJ, Wang, W, Benjamin, RS, Bishop, AJ, Madewell, JE, Murphy Jr, WA, Costelloe, C. Novel Use and Value of Contrast-Enhanced Susceptibility-Weighted Imaging Morphologic and Radiomic Features in Predicting Extremity Soft Tissue Undifferentiated Pleomorphic Sarcoma Treatment Response. JCO Clinical Cancer Informatics 9, 2025. e-Pub 2025. PMID: 39841956.
7. Devarajan, E, Davis, RE, Beird, H, Wang, W, Jensen, VB, Jayakumar, A, Leung, CH, Lin, HY, Wu, C, Ihezie, SA, Tsai, JW, Futreal, A, Lewis, VO. Targeting IL-11R/EZH2 signaling axis as a therapeutic strategy for osteosarcoma lung metastases. Discover Oncology 15(1), 2024. e-Pub 2024. PMID: 38886296.
8. Karim NA, Miao J, Reckamp KL, Gay CM, Byers LA, Zhao YQ, Redman MW, Carrizosa DR, Wang WL, Petty WJ, Mehta K, Faller BA, Agamah ES, Kasbari SS, Malisetti RK, Kumar A, Schallenkamp J, Alluri KC, Gray JE, Kelly K. Phase II randomized study of maintenance atezolizumab (A) versus atezolizumab + talazoparib (AT) in patients with SLFN11 positive extensive stage small cell lung cancer. S1929. J Thorac Oncol 20(3):383-394, 2024. e-Pub 2024. PMID: 39505259.
9. Gingrich A, Wangsiricharoen S, Torres MB, Ravi V, Ratan R, Keung EZ, Scally CP, Lazar AJ, Wang WL, Roland CL, Hunt KK, Yu W, Torres KE. Clinical Variables Influencing Outcomes in Patients with Atypical Intradermal Smooth Muscle Neoplasms (Formerly Cutaneous Leiomyosarcomas): Single-Institution Study of 95 Surgical Patients. Ann Surg Oncol 31(12):7950-7956, 2024. e-Pub 2024. PMID: 39150618.
10. Pineda-Reyes J, Arudra SK, Aung PP, Nagarajan P, Curry JL, Tetzlaff M, Prieto VG, Wang WL, Hwu WJ, Torres-Cabala CA. Dual PD-L1/SOX10 Immunohistochemistry Combined With Digital Imaging Enhances Stratification Accuracy of Patients With Metastatic Melanoma. Am J Surg Pathol 48(12):1551-1556, 2024. e-Pub 2024. PMID: 39373029.
11. Beird HC, Cloutier JM, Gokgoz N, Eeles C, Griffin AM, Ingram DR, Wani KM, Segura RL, Cohen L, Ho C, Wunder JS, Andrulis IL, Futreal PA, Haibe-Kains B, Lazar AJ, Wang WL, Przybyl J, Demicco EG. Epigenomic and transcriptomic profiling of solitary fibrous tumors identifies site-specific patterns and candidate genes regulated by DNA methylation. Lab Invest 104(11):102146, 2024. e-Pub 2024. PMID: 39357799.
12. Valenzuela RF, Duran-Sierra E, Canjirathinkal M, Amini B, Torres KE, Benjamin RS, Ma J, Wang WL, Hwang KP, Stafford RJ, Wu C, Zarzour AM, Bishop AJ, Lo S, Madewell JE, Kumar R, Murphy WA Jr, Costelloe CM. Perfusion-weighted imaging with dynamic contrast enhancement (PWI/DCE) morphologic, qualitative, semiquantitative, and radiomics features predicting undifferentiated pleomorphic sarcoma (UPS) treatment response. Sci Rep 14(1):21681, 2024. e-Pub 2024. PMID: 39289469.
13. Lazcano R, Ingram DR, Panse G, Lazar AJ, Wang WL, Cloutier JM. TRPS1 expression in MPNST is correlated with PRC2 inactivation and loss of H3K27me3. Hum Pathol 151:105632, 2024. e-Pub 2024. PMID: 39084565.
14. Bishop AJ, Mitra D, Farooqi A, Swanson DM, Hempel C, Willis T, Pearlnath C, Wang WL, Ratan R, Somaiah N, Benjamin RS, Torres KE, Hunt KK, Scally CP, Keung EZ, Satcher RL, Bird JE, Lin PP, Moon BS, Lewis VO, Roland CL, Guadagnolo BA. Moderately hypofractionated, preoperative radiotherapy in patients with soft tissue sarcomas (HYPORT-STS): Updated local control, late toxicities, and patient-reported outcomes. Cancer 131(1), 2024. e-Pub 2024. PMID: 39192597.
15. Nakazawa, MS, Silverman, IM, Rimkunas, V, Veloso, A, Glodzik, D, Johnson, A, Ohsumi, TK, Patel, S, Conley, AP, Roland, CL, Soliman, PT, Beird, H, Wu, C, Ingram, D, Segura Lazcano, R, Song, D, Wani, K, Lazar, A, Yap, TA, Wang, W, Andrew Livingston, J. Loss of the DNA Repair Gene RNase H2 Identifies a Unique Subset of DDR-Deficient Leiomyosarcomas. Molecular cancer therapeutics 23(7):1057-1065, 2024. e-Pub 2024. PMID: 38561019.
16. Coconubo DM, Wangsiricharoen S, Pettus JR, Linos K, Pinto A, Wang WL, Kerr DA, Cloutier JM. A Subset of Thoracic SMARCA4-Deficient Undifferentiated Tumors Express GATA3. Int J Surg Pathol 32(4):10668969231188904, 2024. e-Pub 2023. PMID: 37461275.
17. Pilie, PG, Giuliani, V, Wang, W, McGrail, DJ, Bristow, C, Ngoi, NY, Kyewalabye, K, Wani, K, Le, H, Campbell, E, Sánchez, N, Yang, D, Gheeya, J, Goswamy, R, Holla, V, Shaw, KR, Meric-Bernstam, F, Liu, CY, Ma, X, Feng, N, Machado, AA, Bardenhagen, J, Vellano, CP, Marszalek, JR, Rajendra, E, Piscitello, D, Johnson, TI, Likhatcheva, M, Elinati, E, Majithiya, J, Neves, J, Grinkevich, V, Ranzani, M, Luzarraga, MR, Boursier, M, Armstrong, L, Geo, L, Lillo, G, Tse, WY, Lazar, A, Kopetz, S, Do, MK, Lively, S, Johnson, MG, Robinson, HM, Smith, GC, Carroll, C, Di, MF, Jones, PH, Heffernan, TP, Yap, TA. Ataxia-Telangiectasia Mutated Loss-of-Function Displays Variant and Tissue-Specific Differences across Tumor Types. Clinical Cancer Research 30(10):2121-2139, 2024. e-Pub 2024. PMID: 38416404.
18. Denu, RA, Joseph, CP, Urquiola, E, Byrd, PS, Yang, RK, Ratan, R, Zarzour, MA, Conley, AP, Araujo, DM, Ravi, V, Nassif, EF, Nakazawa, MS, Patel, S, Wang, W, Lazar, A, Somaiah, N. Utility of Clinical Next Generation Sequencing Tests in KIT/PDGFRA/SDH Wild-Type Gastrointestinal Stromal Tumors. Cancers 16(9), 2024. e-Pub 2024. PMID: 38730662.
19. Paindelli, C, Parietti, V, Barrios, S, Shepherd, P, Pan, T, Wang, W, Satcher, R, Logothetis, CJ, Navone, NM, Campbell, M, Mikos, AG, Dondossola, E. Bone mimetic environments support engineering, propagation, and analysis of therapeutic response of patient-derived cells, ex vivo and in vivo. Acta Biomaterialia 178:83-92, 2024. e-Pub 2024. PMID: 38387748.
20. Roland CL, Nassif Haddad EF, Keung EZ, Wang WL, Lazar AJ, Lin H, Chelvanambi M, Parra ER, Wani K, Guadagnolo BA, Bishop AJ, Burton EM, Hunt KK, Torres KE, Feig BW, Scally CP, Lewis VO, Bird JE, Ratan R, Araujo D, Zarzour MA, Patel S, Benjamin R, Conley AP, Livingston JA, Ravi V, Tawbi HA, Lin PP, Moon BS, Satcher RL, Mujtaba B, Witt RG, Traweek RS, Cope B, Lazcano R, Wu CC, Zhou X, Mohammad MM, Chu RA, Zhang J, Damania A, Sahasrabhojane P, Tate T, Callahan K, Nguyen S, Ingram D, Morey R, Crosby S, Mathew G, Duncan S, Lima CF, Blay JY, Fridman WH, Shaw K, Wistuba I, Futreal A, Ajami N, Wargo JA, Somaiah N. A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma. Nat Cancer 5(4):625-641, 2024. e-Pub 2024. PMID: 38351182.
21. Wangsiricharoen, S, Ingram, D, Morey, R, Wani, K, Lazar, A, Wang, W. Glycoprotein Nonmetastatic Melanoma Protein B (GPNMB) Immunohistochemistry Can Be a Useful Ancillary Tool to Identify Perivascular Epithelioid Cell Tumor. Modern Pathology 37(3), 2024. e-Pub 2024. PMID: 38219952.
22. Marques-Piubelli ML, Kumar B, Basar R, Panowski S, Srinivasan S, Norwood K, Prashad S, Szenes V, Balakumaran A, Arandhya A, Lu W, Khan K, Duenas D, McAllen S, Gomez JA, Burks JK, Acharyal S, Borthakur G, Wang WL, Wang W, Wang S, Solis LM, Marin D, Rezvani K, Daher M, Vega F. Increased expression of CD70 in relapsed acute myeloid leukemia after hypomethylating agents. Virchows Arch, 2024. e-Pub 2024. PMID: 38388965.
23. Kerr, DA, Cloutier, JM, Margolis, M, Mata, DA, Rodrigues Simoes, NJ, Faquin, WC, Dias-Santagata, D, Chopra, S, Charville, GW, Wangsiricharoen, S, Lazar, A, Wang, W, Rosenberg, AE, Tse, JY. GLI1-Altered Mesenchymal Tumors With ACTB or PTCH1 Fusion. Modern Pathology 37(2), 2024. e-Pub 2024. PMID: 37992966.
24. Hu, J, Lazar, A, Ingram, D, Wang, W, Zhang, W, Jia, Z, Ragoonanan, D, Wang, J, Xia, X, Mahadeo, KM, Gorlick, R, Li, S. Cell membrane-anchored and tumor-targeted IL-12 T-cell therapy destroys cancer-associated fibroblasts and disrupts extracellular matrix in heterogenous osteosarcoma xenograft models. Journal for immunotherapy of cancer 12(1), 2024. e-Pub 2024. PMID: 38199607.
25. Beird HC, Wu CC, Nakazawa M, Ingram D, Daniele JR, Lazcano R, Little L, Davies C, Daw NC, Wani K, Wang WL, Song X, Gumbs C, Zhang J, Rubin B, Conley A, Flanagan AM, Lazar AJ, Futreal PA. Complete loss of TP53 and RB1 is associated with complex genome and low immune infiltrate in pleomorphic rhabdomyosarcoma. HGG Adv 4(4):100224, 2023. e-Pub 2023. PMID: 37593416.
26. Warmke LM, Wang WL, Baumhoer D, Andrei V, Ameline B, Baker ML, Kerr DA. TAF15::NR4A3 gene fusion identifies a morphologically distinct subset of extraskeletal myxoid chondrosarcoma mimicking myoepithelial tumors. Genes Chromosomes Cancer 62(10):581-588, 2023. e-Pub 2023. PMID: 37057757.
27. Cho WC, Li W, Gu J, Wang WL, Ning J, Sfamenos S, Gill P, Nagarajan P, Curry JL, Lazar AJ, Prieto VG, Torres-Cabala CA, Aung PP. Telomerase reverse transcriptase immunohistochemical expression is sensitive but not specific for TERT gene amplification in acral melanoma. J Cutan Pathol 50(9):845-851, 2023. e-Pub 2023. PMID: 37400233.
28. Amini B, Chenglei L, Duran-Sierra E, Wang WL, Canjirathinkal MA, Moradi H, Green WN, Madewell JE, Costelloe CM, Murphy WA Jr, Valenzuela RF. Role of Apparent Diffusion Coefficient Map-Based First- and High-Order Radiomic Features for the Discrimination of Sacral Chordomas and Chondrosarcomas With Overlapping Conventional Imaging Features. JCO Precis Oncol 7:e2300243, 2023. e-Pub 2023. PMID: 38127828.
29. Gangahar CN, Dehner CA, Wang DP, Amini B, Hillen T, O'Conor C, Jennings SN, Byrnes K, Montgomery EA, Czerniak BA, Bridge JA, Schroeder MC, Jennings JW, Wang WL, Chrisinger JSA. Intraosseous hibernoma: clinicopathologic and imaging analysis of 18 cases. Histopathology 83(1):40-48, 2023. e-Pub 2023. PMID: 37099409.
30. Carmagnani Pestana R, Moyers JT, Roszik J, Sen S, Hong DS, Naing A, Herzog CE, Fu S, Piha-Paul SA, Rodon J, Yap TA, Karp DD, Tsimberidou AM, Pant S, Zarzour MA, Ratan R, Ravi V, Benjamin RS, Lazar AJ, Wang WL, Daw N, Gill JB, Harrison DJ, Lewis VO, Roland CL, Patel SR, Livingston JA, Somaiah N, Ludwig JA, Conley AP, Hamerschlak N, Gorlick R, Meric-Bernstam F, Subbiah V. Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101). Clin Cancer Res 29(9):OF1-OF11, 2023. e-Pub 2023. PMID: 37058010.
31. Cho WC, Ding Q, Wang WL, Nagarajan P, Curry JL, Torres-Cabala CA, Ivan D, Albarracin CT, Sahin A, Prieto VG, Aung PP. Immunohistochemical expression of TRPS1 in mammary Paget disease, extramammary Paget disease, and their close histopathologic mimics. J Cutan Pathol 50(5):434-440, 2023. e-Pub 2023. PMID: 36808637.
32. Alhalabi O, Zhu Y, Hamza A, Qiao W, Lin Y, Wang RM, Shah AY, Campbell MT, Holla V, Kamat A, Wang WL, Wang J, Chen J, Meng J, Zhang M, Bondaruk J, Titus M, Genovese G, Czerniak BA, Shaw KR, Meric-Bernstam F, Guo CC, Logothetis CJ, Siefker-Radtke A, Msaouel P, Wang L, Liu J, Gao J. Integrative Clinical and Genomic Characterization of MTAP-deficient Metastatic Urothelial Cancer. Eur Urol Oncol 6(2):228-232, 2023. e-Pub 2023. PMID: 34789422.
33. Ronen S, Ko JS, Rubin BP, Kilpatrick SE, Wang WL, Lazar AJ, Goldblum JR, Billings SD. Superficial Low-grade Fibromyxoid Sarcoma. J Cutan Pathol 50(2):147-154, 2023. e-Pub 2023. PMID: 36074249.
34. Thirasastr P, Lin H, Amini B, Wang WL, Cloutier JM, Nassif EF, Keung EZ, Roland CL, Feig B, Araujo D, Benjamin RS, Conley AP, Livingston JA, Ludwig J, Patel S, Ratan R, Ravi V, Zarzour MA, Zhou X, Somaiah N. Retrospective evaluation of the role of gemcitabine-docetaxel in well-differentiated and dedifferentiated liposarcoma. Cancer Med 12(4):4282-4293, 2023. e-Pub 2023. PMID: 36151848.
35. Cho WC, Vanderbeck K, Nagarajan P, Milton DR, Gill P, Wang WL, Curry JL, Torres-Cabala CA, Ivan D, Prieto VG, Aung PP. SOX11 Is an Effective Discriminatory Marker, When Used in Conjunction With CK20 and TTF1, for Merkel Cell Carcinoma. Arch Pathol Lab Med. e-Pub 2023. PMID: 36745184.
36. Chen H, Ding Q, Khazai L, Zhao L, Damodaran S, Litton JK, Rauch GM, Yam C, Chang JT, Seth S, Lim B, Thompson AM, Mittendorf EA, Adrada B, Virani K, White JB, Ravenberg E, Song X, Candelaria R, Arun B, Ueno NT, Santiago L, Saleem S, Abouharb S, Murthy RK, Ibrahim N, Routbort MJ, Sahin A, Valero V, Symmans WF, Tripathy D, Wang WL, Moulder S, Huo L. PTEN in triple-negative breast carcinoma: protein expression and genomic alteration in pretreatment and posttreatment specimens. Ther Adv Med Oncol 15:17588359231189422, 2023. e-Pub 2023. PMID: 37547448.
37. Cloutier JM, Ingram DR, Wani K, Lazar AJ, Wang WL. Frequent TRPS1 expression in synovial sarcoma is associated with SS18-SSX fusion oncoprotein activity. Hum Pathol 130:88-94, 2022. e-Pub 2022. PMID: 36162599.
38. Guadagnolo BA, Bassett RL, Mitra D, Farooqi A, Hempel C, Dorber C, Willis T, Wang WL, Ratan R, Somaiah N, Benjamin RS, Torres KE, Hunt KK, Scally CP, Keung EZ, Satcher RL, Bird JE, Lin PP, Moon BS, Lewis VO, Roland CL, Bishop AJ. Hypofractionated, 3-week, preoperative radiotherapy for patients with soft tissue sarcomas (HYPORT-STS): a single-centre, open-label, single-arm, phase 2 trial. Lancet Oncol 23(12):1547-1557, 2022. e-Pub 2022. PMID: 36343656.
39. Bishop AJ, Amini B, Lin H, Raza SM, Patel S, Grosshans DR, Ghia A, Farooqi A, Guadagnolo BA, Mitra D, Akdemir KC, Lazar AJ, Wang WL, Alvarez-Breckenridge C, Bird J, Rhines LD, Somaiah N, Conley AP. Immune Checkpoint Inhibitors Have Clinical Activity in Patients With Recurrent Chordoma. J Immunother 45(8):374-378, 2022. e-Pub 2022. PMID: 35943386.
40. Cloutier JM, Maloney NS, Wang WL, Lazar AJ. Pigmented PRRX1::NCOA1-rearranged fibroblastic tumor: A rare morphologic variant of an emerging mesenchymal tumor. J Cutan Pathol 49(9):802-807, 2022. e-Pub 2022. PMID: 35583270.
41. Somaiah N, Conley AP, Parra ER, Lin H, Amini B, Solis Soto L, Salazar R, Barreto C, Chen H, Gite S, Haymaker C, Nassif EF, Bernatchez C, Mitra A, Livingston JA, Ravi V, Araujo DM, Benjamin R, Patel S, Zarzour MA, Sabir S, Lazar AJ, Wang WL, Daw NC, Zhou X, Roland CL, Cooper ZA, Rodriguez-Canales J, Futreal A, Soria JC, Wistuba II, Hwu P. Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trial. Lancet Oncol 23(9):1156-1166, 2022. e-Pub 2022. PMID: 35934010.
42. Warmke LM, Maloney N, Leung CH, Lin H, Lazar AJ, Wang WL. SATB2 Expression in Undifferentiated Pleomorphic Sarcomas of Bone. Am J Clin Pathol 158(2):235-241, 2022. e-Pub 2022. PMID: 35311957.
43. Hingorani P, Zhang W, Zhang Z, Xu Z, Wang WL, Roth ME, Wang Y, Gill JB, Harrison DJ, Teicher BA, Erickson SW, Gatto G, Kolb EA, Smith MA, Kurmasheva RT, Houghton PJ, Gorlick R. Trastuzumab deruxtecan, antibody-drug conjugate targeting HER2, is effective in pediatric solid tumors: A report by the Pediatric Preclinical Testing Consortium. Mol Cancer Ther 21(8):1318-1325, 2022. e-Pub 2022. PMID: 35657346.
44. Zhang B, Stewart CA, Wang Q, Cardnell RJ, Rocha P, Fujimoto J, Solis Soto LM, Wang R, Novegil V, Ansell P, He L, Fernandez L, Jendrisak A, Gilbertson C, Schonhoft JD, Byun J, Jones J, Anderson AKL, Aparicio A, Tran H, Negrao MV, Zhang J, Wang WL, Wistuba II, Wang J, Wenstrup R, Byers LA, Gay CM. Dynamic expression of Schlafen 11 (SLFN11) in circulating tumour cells as a liquid biomarker in small cell lung cancer. Br J Cancer 127(3):569-576, 2022. e-Pub 2022. PMID: 35440668.
45. Dehner CA, Sadegh D, Boulos F, Messias N, Wang WL, Demicco EG, Chrisinger JSA. Clear cell stromal tumour of the lung with YAP1::TFE3 fusion: four cases including a case with highly aggressive clinical course. Histopathology 81(2):239-245, 2022. e-Pub 2022. PMID: 35762906.
46. Dehner CA, Maloney N, Amini B, Jennings JW, McDonald DJ, Wang WL, Chrisinger JSA. Dedifferentiated chondrosarcoma with minimal or small dedifferentiated component. Mod Pathol 35(7):922-928, 2022. e-Pub 2022. PMID: 35115636.
47. Shen T, Zhao J, Zhao M, Taggart MW, Ramalingam P, Gong Y, Wu Y, Liu H, Zhang J, Resetkova E, Wang WL, Ding Q, Huo L, Yoon E. Unusual Staining of Immunohistochemical Markers PAX8 and CDX2 in Breast Carcinoma: A Potential Diagnostic Pitfall. Hum Pathol 125:35-47, 2022. e-Pub 2022. PMID: 35417734.
48. Nassif EF, Cope B, Traweek R, Witt RG, Erstad DJ, Scally CP, Thirasastr P, Zarzour MA, Ludwig J, Benjamin R, Bishop AJ, Guadagnolo BA, Ingram D, Wani K, Wang WL, Lazar AJ, Torres KE, Hunt KK, Feig BW, Roland CL, Somaiah N, Keung EZ. Real-World Use of Palbociclib Monotherapy in Retroperitoneal Liposarcomas at a Large Volume Sarcoma Center. Int J Cancer 150(12):2012-2024, 2022. e-Pub 2022. PMID: 35128664.
49. Lamhamedi-Cherradi SE, Maitituoheti M, Menegaz BA, Krishnan S, Vetter AM, Camacho P, Wu CC, Beird HC, Porter RW, Ingram DR, Ramamoorthy V, Mohiuddin S, McCall D, Truong DD, Cuglievan B, Futreal PA, Velasco AR, Anvar NE, Utama B, Titus M, Lazar AJ, Wang WL, Rodriguez-Aguayo C, Ratan R, Livingston JA, Rai K, MacLeod AR, Daw NC, Hayes-Jordan A, Ludwig JA. The androgen receptor is a therapeutic target in desmoplastic small round cell sarcoma. Nat Commun 13(1):3057, 2022. e-Pub 2022. PMID: 35650195.
50. Zullow HJ, Sankar A, Ingram DR, Samé Guerra DD, D'Avino AR, Collings CK, Lazcano R, Wang WL, Liang Y, Qi J, Lazar AJ, Kadoch C. The FUS::DDIT3 fusion oncoprotein inhibits BAF complex targeting and activity in myxoid liposarcoma. Mol Cell 82(9):1737-1750.e8, 2022. e-Pub 2022. PMID: 35390276.
51. Alhalabi O, Chen J, Zhang Y, Lu Y, Wang Q, Ramachandran S, Tidwell RS, Han G, Yan X, Meng J, Wang R, Hoang AG, Wang WL, Song J, Lopez L, Andreev-Drakhlin A, Siefker-Radtke A, Zhang X, Benedict WF, Shah AY, Wang J, Msaouel P, Zhang M, Guo CC, Czerniak B, Behrens C, Soto L, Papadimitrakopoulou V, Lewis J, Rinsurongkawong W, Rinsurongkawong V, Lee J, Roth J, Swisher S, Wistuba I, Heymach J, Wang J, Campbell MT, Efstathiou E, Titus M, Logothetis CJ, Ho TH, Zhang J, Wang L, Gao J. MTAP deficiency creates an exploitable target for antifolate therapy in 9p21-loss cancers. Nat Commun 13(1):1797, 2022. e-Pub 2022. PMID: 35379845.
52. McQuaid DC, Panse G, Wang WL, Pinkus GS, Katz SG, Xu ML. Global Assessment of IRF8 as a Novel Cancer Biomarker. Hum Pathol 122:1-10, 2022. e-Pub 2022. PMID: 35085599.
53. Hu S, Alpert L, Cates JMM, Gonzalez RS, Stratification Group RGR. Gastrointestinal stromal tumors (GISTs) arising in uncommon locations: clinicopathologic features and risk assessment of esophageal, colonic, and appendiceal GISTs. Mod Pathol 35(4):554-563, 2022. e-Pub 2022. PMID: 34702994.
54. Dinarvand P, Wang WL, Roy-Chowdhuri S. Utility of SOX11 for the diagnosis of solid pseudopapillary neoplasm of the pancreas on cytological preparations. Cytopathology 33(2):216-221, 2022. e-Pub 2022. PMID: 34816516.
55. Wang J, Wang WL, Sun H, Huo L, Wu Y, Chen H, Gan Q, Meis JM, Maloney N, Lazar AJ, Yoon EC, Albarracin CT, Krishnamurthy S, Middleton LP, Resetkova E, Yu W, Tan D, Lu W, Solis Soto LM, Wang S, Wistuba II, Parwani AV, Prieto VG, Sahin AA, Li Z, Ding Q. Expression of TRPS1 in phyllodes tumor and sarcoma of the breast. Hum Pathol 121:73-80, 2022. e-Pub 2022. PMID: 35063444.
56. Chopra S, Maloney N, Wang WL. Epithelioid inflammatory myofibroblastic sarcoma with VCL-ALK fusion of central nervous system: case report and brief review of the literature. Brain Tumor Pathol 39(1):35-42, 2022. e-Pub 2022. PMID: 34743247.
57. Chopra S, Maloney N, Wang WL. Correction to: Epithelioid inflammatory myofibroblastic sarcoma with VCL-ALK fusion of central nervous system: case report and brief review of the literature. Brain Tumor Pathol 39(1):43, 2022. e-Pub 2022. PMID: 34984581.
58. Lazcano R, Barreto CM, Salazar R, Carapeto F, Traweek RS, Leung CH, Gite S, Mehta J, Ingram DR, Wani KM, Vu KT, Parra ER, Lu W, Zhou J, Witt RG, Cope B, Thirasastr P, Lin HY, Scally CP, Conley AP, Ratan R, Livingston JA, Zarzour AM, Ludwig J, Araujo D, Ravi V, Patel S, Benjamin R, Wargo J, Wistuba II, Somaiah N, Roland CL, Keung EZ, Solis L, Wang WL, Lazar AJ, Nassif EF. The immune landscape of undifferentiated pleomorphic sarcoma. Front Oncol 12:1008484, 2022. e-Pub 2022. PMID: 36313661.
59. Molina ER, Chim LK, Lamhamedi-Cherradi SE, Mohiuddin S, McCall D, Cuglievan B, Krishnan S, Porter RW, Ingram DR, Wang WL, Lazar AJ, Scott DW, Truong DD, Daw NC, Ludwig JA, Mikos AG. Correlation of nuclear pIGF-1R/IGF-1R and YAP/TAZ in a tissue microarray with outcomes in osteosarcoma patients. Oncotarget 13(1):521-533, 2022. e-Pub 2022. PMID: 35284040.
60. Kibbi N, Wang D, Wang WL, Galan A, Leffell DJ, Christensen SR, Panse G. Dermatofibrosarcoma protuberans in pregnancy: a case series and review of the literature. Int J Dermatol 60(9):1114-1119, 2021. e-Pub 2021. PMID: 33818755.
61. Kochat V, Raman AT, Landers SM, Tang M, Schulz J, Terranova C, Landry JP, Bhalla AD, Beird HC, Wu CC, Jiang Y, Mao X, Lazcano R, Gite S, Ingram DR, Yi M, Zhang J, Keung EZ, Scally CP, Roland CL, Hunt KK, Feig BW, Futreal PA, Hwu P, Wang WL, Lazar AJ, Slopis JM, Wilson-Robles H, Wiener DJ, McCutcheon IE, Wustefeld-Janssens B, Rai K, Torres KE. Enhancer reprogramming in PRC2-deficient malignant peripheral nerve sheath tumors induces a targetable de-differentiated state. Acta Neuropathol 142(3):565-590, 2021. e-Pub 2021. PMID: 34283254.
62. Schaefer IM, Lundberg MZ, Demicco EG, Przybyl J, Matusiak M, Chibon F, Ingram DR, Hornick JL, Wang WL, Bauer S, Baker LH, Lazar AJ, van de Rijn M, Mariño-Enríquez A, Fletcher JA. Relationships between highly recurrent tumor suppressor alterations in 489 leiomyosarcomas. Cancer 127(15):2666-2673, 2021. e-Pub 2021. PMID: 33788262.
63. Cho WC, Wang WL, Milton DR, Ingram DR, Nagarajan P, Curry JL, Ivan D, Lazar AJ, Hwu WJ, Prieto VG, Torres-Cabala CA, Aung PP. Telomerase Reverse Transcriptase Protein Expression Is More Frequent in Acral Lentiginous Melanoma Than in Other Types of Cutaneous Melanoma. Arch Pathol Lab Med 145(7):842-850, 2021. e-Pub 2021. PMID: 33053175.
64. Weinschenk RC, Wang WL, Lewis VO. Chondrosarcoma. J Am Acad Orthop Surg 29(13):553-562, 2021. e-Pub 2021. PMID: 33595238.
65. Terranova CJ, Tang M, Maitituoheti M, Raman AT, Ghosh AK, Schulz J, Amin SB, Orouji E, Tomczak K, Sarkar S, Oba J, Creasy C, Wu CJ, Khan S, Lazcano R, Wani K, Singh A, Barrodia P, Zhao D, Chen K, Haydu LE, Wang WL, Lazar AJ, Woodman SE, Bernatchez C, Rai K. Reprogramming of bivalent chromatin states in NRAS mutant melanoma suggests PRC2 inhibition as a therapeutic strategy. Cell Rep 36(3):109410, 2021. e-Pub 2021. PMID: 34289358.
66. Wang WL, Gokgoz N, Samman B, Andrulis IL, Wunder JS, Demicco EG. RNA expression profiling reveals PRAME, a potential immunotherapy target, is frequently expressed in solitary fibrous tumors. Mod Pathol 34(5):951-960, 2021. e-Pub 2021. PMID: 33009490.
67. Wagner MJ, Lyons YA, Siedel JH, Dood R, Nagaraja AS, Haemmerle M, Mangala LS, Chanana P, Lazar AJ, Wang WL, Ravi V, Holland EC, Sood AK. Combined VEGFR and MAPK pathway inhibition in angiosarcoma. Sci Rep 11(1):9362, 2021. e-Pub 2021. PMID: 33931674.
68. Parkes A, Wang WL, Patel S, Leung CH, Lin H, Conley AP, Somaiah N, Araujo DM, Zarzour M, Livingston JA, Ludwig J, Roland CL, Ravi V, Benjamin RS, Ratan R. Outcomes of systemic therapy in metastatic phyllodes tumor of the breast. Breast Cancer Res Treat 186(3):871-882, 2021. e-Pub 2021. PMID: 33575859.
69. Warmke LM, Tinkham EG, Ingram DR, Lazar AJ, Panse G, Wang WL. INSM1 Expression in Angiosarcoma. Am J Clin Pathol 155(4):575-580, 2021. e-Pub 2021. PMID: 33210141.
70. Boyce-Fappiano D, Guadagnolo BA, Ratan R, Wang WL, Wagner MJ, Patel S, Livingston JA, Lin PP, Diao K, Mitra D, Farooqi A, Lazar AJ, Roland CL, Bishop AJ. Evaluating the Soft Tissue Sarcoma Paradigm for the Local Management of Extraskeletal Ewing Sarcoma. Oncologist 26(3):250-260, 2021. e-Pub 2020. PMID: 33289298.
71. Huang X, Ding Q, Guo H, Gong Y, Zhao J, Zhao M, Sui D, Wu Y, Chen H, Liu H, Zhang J, Resetkova E, Moulder SL, Wang WL, Huo L. Comparison of three FDA-approved diagnostic immunohistochemistry assays of PD-L1 in triple-negative breast carcinoma. Hum Pathol 108:42-50, 2021. e-Pub 2020. PMID: 33221342.
72. Panse G, Reisenbichler E, Snuderl M, Wang WL, Laskin W, Jour G. LMNA-NTRK1 rearranged mesenchymal tumor (lipofibromatosis-like neural tumor) mimicking pigmented dermatofibrosarcoma protuberans. J Cutan Pathol 48(2):290-294, 2021. e-Pub 2021. PMID: 32519338.
73. Li P, Laskin W, Wang WL, Demicco EG, Panse G. Primary superficial synovial sarcoma: clinical and histopathological characteristics in eight cases with molecular confirmation. J Cutan Pathol 48(2):263-268, 2021. e-Pub 2021. PMID: 32996614.
74. Kumar R, Lefkowitz RA, Agaram NP, Amini B, Satcher RL, Wang WL. Spindle Cell Lipoma Revisited: Common and Unusual Magnetic Resonance Imaging Findings in 54 Patients With New Observations. J Comput Assist Tomogr 45(4):564-570, 2021. e-Pub 2021. PMID: 34270478.
75. Rathore R, Caldwell KE, Schutt C, Brashears CB, Prudner BC, Ehrhardt WR, Leung CH, Lin H, Daw NC, Beird HC, Giles A, Wang WL, Lazar AJ, Chrisinger JSA, Livingston JA, Van Tine BA. Metabolic compensation activates pro-survival mTORC1 signaling upon 3-phosphoglycerate dehydrogenase inhibition in osteosarcoma. Cell Rep 34(4):108678, 2021. e-Pub 2021. PMID: 33503424.
76. Panse G, Mito JK, Ingram DR, Wani K, Khan S, Lazar AJ, Doyle LA, Wang WL. Radiation-Associated Sarcomas other than Malignant Peripheral Nerve Sheath Tumors Demonstrate Loss of Histone H3K27 Trimethylation. Histopathology 78(2):321-326, 2021. e-Pub 2021. PMID: 32735735.
77. Qin Y, Bollin K, de Macedo MP, Carapeto F, Kim KB, Roszik J, Wani KM, Reuben A, Reddy ST, Williams MD, Tetzlaff MT, Wang WL, Gombos DS, Esmaeli B, Lazar AJ, Hwu P, Patel SP. Immune profiling of uveal melanoma identifies a potential signature associated with response to immunotherapy. J Immunother Cancer 8(2), 2020. e-Pub 2020. PMID: 33203661.
78. Maitituoheti M, Keung EZ, Tang M, Yan L, Alam H, Han G, Singh AK, Raman AT, Terranova C, Sarkar S, Orouji E, Amin SB, Sharma S, Williams M, Samant NS, Dhamdhere M, Zheng N, Shah T, Shah A, Axelrad JB, Anvar NE, Lin YH, Jiang S, Chang EQ, Ingram DR, Wang WL, Lazar A, Lee MG, Muller F, Wang L, Ying H, Rai K. Enhancer Reprogramming Confers Dependence on Glycolysis and IGF Signaling in KMT2D Mutant Melanoma. Cell Rep 33(3):108293, 2020. e-Pub 2020. PMID: 33086062.
79. Yalniz C, Meis JM, Wang WL, Huo L, Candelaria RP, Adrada BE, Lane D, Santiago L, Huang ML. Proliferative fasciitis mimicking sarcoma in the breast. Breast J. e-Pub 2020. PMID: 32854140.
80. Amin HM, Morani AC, Daw NC, Lamhamedi-Cherradi SE, Subbiah V, Menegaz BA, Vishwamitra D, Eskandari G, George B, Benjamin RS, Patel S, Song J, Lazar AJ, Wang WL, Kurzrock R, Pappo A, Anderson PM, Schwartz GK, Araujo D, Cuglievan B, Ratan R, McCall D, Mohiuddin S, Livingston JA, Molina ER, Naing A, Ludwig JA. IGF-1R/mTOR Targeted Therapy for Ewing Sarcoma: A Meta-Analysis of Five IGF-1R-Related Trials Matched to Proteomic and Radiologic Predictive Biomarkers. Cancers (Basel) 12(7), 2020. e-Pub 2020. PMID: 32630797.
81. Bishop AJ, Landry JP, Roland CL, Ratan R, Feig BW, Moon BS, Zarzour MA, Wang WL, Lazar AJ, Lewis VO, Torres KE, Guadagnolo BA. Certain risk factors for patients with desmoid tumors warrant reconsideration of local therapy strategies. Cancer 126(14):3265-3273, 2020. e-Pub 2020. PMID: 32343846.
82. Guo H, Ding Q, Gong Y, Gilcrease MZ, Zhao M, Zhao J, Sui D, Wu Y, Chen H, Liu H, Zhang J, Resetkova E, Moulder SL, Wang WL, Huo L. Comparison of three scoring methods using the FDA-approved 22C3 immunohistochemistry assay to evaluate PD-L1 expression in breast cancer and their association with clinicopathologic factors. Breast Cancer Res 22(1):69, 2020. e-Pub 2020. PMID: 32576238.
83. Abbas HA, Amini B, Wang WL, Ravi V. Maneuvering the Management of a Rare Case of Primary Undifferentiated Cardiac Sarcoma. Am J Case Rep 21:e918878, 2020. e-Pub 2020. PMID: 32198341.
84. Keung EZ, Burgess M, Salazar R, Parra ER, Rodrigues-Canales J, Bolejack V, Van Tine BA, Schuetze SM, Attia S, Riedel RF, Hu J, Okuno SH, Priebat DA, Movva S, Davis LE, Reed DR, Reuben A, Roland CL, Reinke D, Lazar AJ, Wang WL, Wargo JA, Tawbi HA. Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab. Clin Cancer Res 26(6):1258-1266, 2020. e-Pub 2020. PMID: 31900276.
85. Wu CC, Beird HC, Andrew Livingston J, Advani S, Mitra A, Cao S, Reuben A, Ingram D, Wang WL, Ju Z, Hong Leung C, Lin H, Zheng Y, Roszik J, Wang W, Patel S, Benjamin RS, Somaiah N, Conley AP, Mills GB, Hwu P, Gorlick R, Lazar A, Daw NC, Lewis V, Futreal PA. Immuno-genomic landscape of osteosarcoma. Nat Commun 11(1):1008, 2020. e-Pub 2020. PMID: 32081846.
86. Petitprez F, de Reyniès A, Keung EZ, Chen TW, Sun CM, Calderaro J, Jeng YM, Hsiao LP, Lacroix L, Bougoüin A, Moreira M, Lacroix G, Natario I, Adam J, Lucchesi C, Laizet YH, Toulmonde M, Burgess MA, Bolejack V, Reinke D, Wani KM, Wang WL, Lazar AJ, Roland CL, Wargo JA, Italiano A, Sautès-Fridman C, Tawbi HA, Fridman WH. B cells are associated with survival and immunotherapy response in sarcoma. Nature 577(7791):556-560, 2020. e-Pub 2020. PMID: 31942077.
87. Landers SM, Bhalla AD, Ma X, Lusby K, Ingram D, Al Sannaa G, Wang WL, Lazar AJ, Torres KE. AXL Inhibition Enhances MEK Inhibitor Sensitivity in Malignant Peripheral Nerve Sheath Tumors. J Cancer Sci Clin Ther 4(4):511-525, 2020. e-Pub 2020. PMID: 33283192.
88. Dupuis M, Shen Y, Curcio C, Meis JM, Wang WL, Amini B, Rhines L, Reuther J, Roy A, Fisher KE, Conley AP, Andrew Livingston J. Successful Treatment of Lipofibromatosis-Like Neural Tumor of the Lumbar Spine with an NTRK-Fusion Inhibitor. Clin Sarcoma Res 10:14, 2020. e-Pub 2020. PMID: 32782782.
89. Parkes A, Urquiola E, Bhosale P, Lin H, Watson K, Wang WL, Feig B, Torres K, Roland CL, Conley AP, Zarzour M, Livingston JA, Ratan R, Ludwig J, Araujo DM, Ravi V, Benjamin RS, Patel S, Somaiah N. PET/CT Imaging as a Diagnostic Tool in Distinguishing Well-Differentiated versus Dedifferentiated Liposarcoma. Sarcoma 2020:8363986, 2020. e-Pub 2020. PMID: 32565716.
90. Ali AMR, Tsai JW, Leung CH, Lin H, Ravi V, Conley AP, Lazar AJ, Wang WL, Nathenson MJ. The immune microenvironment of uterine adenosarcomas. Clin Sarcoma Res 10:5, 2020. e-Pub 2020. PMID: 32231779.
91. Demicco EG, Griffin AM, Gladdy RA, Dickson BC, Ferguson PC, Swallow CJ, Wunder JS, Wang WL. Comparison of Published Risk Models to Predict Outcome in Extrameningeal Solitary Fibrous Tumor. Histopathology 75(5):723-737, 2019. e-Pub 2019. PMID: 31206727.
92. Bishop AJ, Bird JE, Conley AP, Roland CL, Moon BS, Satcher RL, Livingston JA, Patel S, Wang WL, Lazar AJ, Lewis VO, Lin PP, Guadagnolo BA. Extraskeletal Myxoid Chondrosarcomas: Combined Modality Therapy with both Radiation and Surgery Improves Local Control. Am J Clin Oncol 42(10):744-748, 2019. e-Pub 2019. PMID: 31436747.
93. Chopra S, Lazar AJ, Wang WL. Are ALK Rearrangements Found in Smooth Muscle Tumors of the Gastrointestinal Tract?. Histopathology. e-Pub 2019. PMID: 31596959.
94. Phadnis SS, Chen L, Wang WL, Migden MR, Zaky W. Disseminated anaplastic pleomorphic xanthoastrocytoma with posttreatment fat necrosis during combined BRAF and MEK inhibitors therapy. Pediatr Blood Cancer:e27974. e-Pub 2019. PMID: 31502413.
95. Raza SM, Habib A, Wang WL, Gildey PW, Conley AP, Nader ME, Hanna EY, Su SY, DeMonte F. Surgical Management of Primary Skull Base Osteosarcomas: Impact of Margin Status and Patterns of Relapse. Neurosurgery. e-Pub 2019. PMID: 31515560.
96. Chrisinger JSA, Al-Zaid T, Keung EZ, Leung CH, Lin HY, Roland CL, Torres KE, Benjamin RS, Ingram DR, Khan S, Somaiah N, Amini B, Feig BW, Lazar AJ, Wang WL. The Degree of Sclerosis in Well-Differentiated Liposarcoma of the Retroperitoneum is Predictive of Behavior. J Surg Oncology 120(3):382-388, 2019. e-Pub 2019. PMID: 31206726.
97. Martinez-Morilla S, McGuire J, Gaule P, Moore L, A Balazs A, Cougot D, Gown A, Yaziji H, Wang WL, Cartun R, Hornick J, Sholl L, Qiu J, Mino-Kenudson M, Yi E, Beasley MB, Merrick D, Ambaye A, Zhang Z, Walker J, Rimm D. Quantitative Assessment of PD-L1 as an Analyte in Immunohistochemistry Diagnostic Assays using a Standardized Cell Line Tissue Microarray. Laboratory Investigation. e-Pub 2019. PMID: 31409885.
98. Nagarajan P, Piao J, Ning J, Noordenbos LE, Curry JL, Torres-Cabala CA, Diwan AH, Ivan D, Aung PP, Ross MI, Royal RE, Wargo JA, Wang WL, Samdani R, Lazar AJ, Rashid A, Davies MA, Prieto VG, Gershenwald JE, Tetzlaff MT. Prognostic model for patient survival in primary anorectal mucosal melanoma: stage at presentation determines relevance of histopathologic features. Mod Pathol. e-Pub 2019. PMID: 31383963.
99. Conley AP, Wang WL, Livingston JA, Ravi V, Tsai JW, Ali A, Ingram DR, Lowery CD, Roland CL, Somaiah N, Hwu P, Yee C, Subbiah V, Futreal A, Lazar AJ, Patel S, Roszik J. MAGE-A3 is a Clinically Relevant Target in Undifferentiated Pleomorphic Sarcoma/Myxofibrosarcoma. Cancers (Basel) 11(5), 2019. e-Pub 2019. PMID: 31096717.
100. Bishop AJ, Zarzour MA, Ratan R, Torres KE, Feig BW, Wang WL, Lazar AJ, Moon BS, Roland CL, Guadagnolo BA. Long-Term Outcomes for Patients With Desmoid Fibromatosis Treated With Radiation Therapy: A 10-Year Update and Re-evaluation of the Role of Radiation Therapy for Younger Patients. Int J Radiat Oncol Biol Phys 103(5):1167-1174, 2019. e-Pub 2019. PMID: 30552963.
101. Rowland F, Call C, Mujtaba B, Amini B, Wang WL. Calcified leiomyoma of the deltoid: pathophysiology and imaging review. Skeletal Radiol 48(4):625-628, 2019. e-Pub 2019. PMID: 30187111.
102. Kairemo K, Wang WL, Subbiah V. Comprehensive molecular imaging of malignant transformation of giant cell tumour of bone reveals diverse disease biology. BMJ Case Rep 12(4), 2019. e-Pub 2019. PMID: 31015231.
103. Bettegowda C, Yip S, Jiang B, Wang WL, Clarke MJ, Lazary A, Gambarotti M, Zhang M, Sciubba DM, Wolinsky JP, Goodwin CR, McCarthy E, Germscheid NM, Sahgal A, Gokaslan ZL, Boriani S, Varga PP, Fisher CG, Rhines LD. Prognostic significance of hTERT (human telomerase reverse transcriptase) promoter region mutations C228T and C250T for overall survival in spinal chordomas. Neuro Oncol. e-Pub 2019. PMID: 30976795.
104. McKean M, Oba J, Ma J, Roth KG, Wang WL, Macedo MP, Carapeto FCL, Haydu LE, Siroy AE, Vo P, Hong DS, Eterovic AK, Patel KP, Bassett RL, Grimm EA, Lazar AJ, Woodman SE. Tyrosine Kinase Inhibitor and Immune Checkpoint Inhibitor Responses in KIT-Mutant Metastatic Melanoma. J Invest Dermatol 139(3):728-731, 2019. e-Pub 2019. PMID: 30798855.
105. Members TF, Vidal CI, Armbrect EA, Andea AA, Bohlke AK, Comfere NI, Hughes SR, Kim J, Kozel JA, Lee JB, Linos K, Litzner BR, Missall TA, Novoa RA, Sundram U, Swick BL, Hurley MY, Panel R, Alam M, Argenyi Z, Duncan LM, Elston DM, Emanuel PO, Ferringer T, Fung MA, Hosler GA, Lazar AJ, Lowe L, Plaza JA, Prieto VG, Robinson JK, Schaffer A, Subtil A, Wang WL. Appropriate Use Criteria in Dermatopathology: Initial Recommendations from the American Society of Dermatopathology. J Am Acad Dermatol 80(1):189-207.e11, 2019. e-Pub 2019. PMID: 29689323.
106. Bashover E, Arriola AG, Joseph CT, Staerkel G, Wang WB, Roy-Chowdhuri S. The use of cytological material in melanoma for programmed death ligand 1 immunostaining. Cytopathology 30(1):61-67, 2019. e-Pub 2019. PMID: 30244524.
107. Bishop AJ, Livingston JA, Araujo DM, Moon BS, Patel S, Wang WL, Lazar AJ, Roland CL, Guadagnolo BA. Extraskeletal Osteosarcomas: A Case Made for Combined Modality Local Therapy With Radiation and Surgery. Am J Clin Oncol. e-Pub 2019. PMID: 30614820.
108. Charville GW, Wang WL, Ingram DR, Roy A, Thomas D, Patel RM, Hornick JL, van de Rijn M, Lazar AJ. PAX7 expression in sarcomas bearing the EWSR1-NFATC2 translocation. Mod Pathol 32(1):154-156, 2019. e-Pub 2019. PMID: 29985454.
109. Goumard C, Marcal LP, Wang WL, Somaiah N, Okuno M, Roland CL, Tzeng CD, Chun YS, Feig BW, Vauthey JN, Conrad C. Long-Term Survival According to Histology and Radiologic Response to Preoperative Chemotherapy in 126 Patients Undergoing Resection of Non-GIST Sarcoma Liver Metastases. Ann Surg Oncol 25(1):107-116, 2018. e-Pub 2018. PMID: 29116489.
110. Demicco EG, Wani K, Ingram D, Wagner M, Maki RG, Rizzo A, Meeker A, Lazar AJ, Wang WL. TERT promoter mutations in solitary fibrous tumour. Histopathology 73(5):843-851, 2018. e-Pub 2018. PMID: 29985536.
111. Arriola AGP, Bashover E, Joseph C, Staerkel G, Wang WL, Roy-Chowdhuri S. The usefulness of various cytologic specimen preparations for PD-L1 immunostaining in non-small cell lung carcinoma. J Am Soc Cytopathol 7(6):324-332, 2018. e-Pub 2018. PMID: 31043303.
112. Kim G, Kurnit KC, Djordjevic B, Singh C, Munsell MF, Wang WL, Lazar AJ, Zhang W, Broaddus R. Nuclear beta-catenin localization and mutation of the CTNNB1 gene: a context-dependent association. Mod Pathol 31(10):1553-1559, 2018. e-Pub 2018. PMID: 29795437.
113. Keung EZ, Lazar AJ, Torres KE, Wang WL, Cormier JN, Ashleigh Guadagnolo B, Bishop AJ, Lin H, Hunt KK, Bird J, Lewis VO, Patel SR, Wargo JA, Somaiah N, Roland CL. Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma. BMC Cancer 18(1):913, 2018. e-Pub 2018. PMID: 30249211.
114. Frezza AM, Jones RL, Lo Vullo S, Asano N, Lucibello F, Ben-Ami E, Ratan R, Teterycz P, Boye K, Brahmi M, Palmerini E, Fedenko A, Vincenzi B, Brunello A, Desar IME, Benjamin RS, Blay JY, Broto JM, Casali PG, Gelderblom H, Grignani G, Gronchi A, Hall KS, Mir O, Rutkowski P, Wagner AJ, Anurova O, Collini P, Dei Tos AP, Flucke U, Hornick JL, Lobmaier I, Philippe T, Picci P, Ranchere D, Renne SL, Sbaraglia M, Thway K, Wagrodzki M, Wang WL, Yoshida A, Mariani L, Kawai A, Stacchiotti S. Anthracycline, Gemcitabine, and Pazopanib in Epithelioid Sarcoma: A Multi-institutional Case Series. JAMA Oncol 4(9):e180219, 2018. e-Pub 2018. PMID: 29800950.
115. Conley AP, Trinh VA, Zobniw CM, Posey K, Martinez JD, Arrieta OG, Wang WL, Lazar AJ, Somaiah N, Roszik J, Patel SR. Positive Tumor Response to Combined Checkpoint Inhibitors in a Patient With Refractory Alveolar Soft Part Sarcoma: A Case Report. J Glob Oncol 4:1-6, 2018. e-Pub 2018. PMID: 30241159.
116. Ikoma N, Roland CL, Torres KE, Chiang YJ, Wang WL, Somaiah N, Mann GN, Hunt KK, Cormier JN, Feig BW. Salvage Surgery for Recurrent Retroperitoneal Well-Differentiated Liposarcoma: Early Reoperation may not Provide Benefit. Ann Surg Oncol 25(8):2193-2200, 2018. e-Pub 2018. PMID: 29520652.
117. Ikoma N, Roland CL, Torres KE, Chiang YJ, Wang WL, Somaiah N, Mann GN, Hunt KK, Cormier JN, Feig BW. Salvage Surgery for Recurrent Retroperitoneal Well-Differentiated Liposarcoma: Early Reoperation May Not Provide Benefit. Annals of Surgical Oncology 25(8):2193-2200, 2018. e-Pub 2018.
118. Yedururi S, Chawla S, Amini B, Wei W, Salem UI, Morani AC, Wang WL, Gorlick R, Lewis VO, Daw NC. Tumor thrombus in the large veins draining primary pelvic osteosarcoma on cross sectional imaging. Eur J Radiol 105:49-55, 2018. e-Pub 2018. PMID: 30017298.
119. Yedururi S, Chawla S, Amini B, Wei W, Salem UI, Morani AC, Wang WL, Gorlick R, Lewis VO, Daw NC. Tumor thrombus in the large veins draining primary pelvic osteosarcoma on cross sectional imaging. European Journal of Radiology, 2018. e-Pub 2018.
120. Nathenson MJ, Conley AP, Lin H, Fleming N, Lazar A, Wang WL, Ravi V. The Importance of Lymphovascular Invasion in Uterine Adenosarcomas: Analysis of Clinical, Prognostic, and Treatment Outcomes. Int J Gynecol Cancer 28(7):1297-1310, 2018. e-Pub 2018. PMID: 30044322.
121. McBride MJ, Pulice JL, Nakayama RT, Beird HC, Ingram DR, D’Avino AR, Shern JF, Charville GR, Hornick JL, Garcia-Rivera ER, Araujo A, Wang WL, Tsai JW, Yeagley M, Wagner AJ, P Andrew Futreal PA, Khan J, Lazar AJ, Kadoch C. The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma. Cancer Cell 33(6):1128-1141, 2018. e-Pub 2018. PMID: 29861296.
122. Zaky W, Patil SS, Park M, Liu D, Wang WL, Wani KM, Calle S, Ketonen L, Khatua S. Ganglioglioma in children and young adults: single institution experience and review of the literature. J Neurooncol. e-Pub 2018. PMID: 29882043.
123. Oba J, Kim SH, Wang WL, Macedo MP, Carapeto F, McKean MA, Arnam JV, Eterovic AK, Sen S, Kale CR, Yu X, Haymaker CL, Routbort M, Haydu L, Bernatchez C, Lazar AJ, Grimm EA, Hong DS, Woodman SE. Targeting the HGF/MET Axis Counters Primary Resistance to KIT Inhibition in KIT-Mutant Melanoma. JCO Precision Oncology(2):1-8, 2018. e-Pub 2018.
124. Smith AL, Williams MD, Stewart J, Wang WL, Krishnamurthy S, Cabanillas ME, Roy-Chowdhuri S. Utility of the BRAF p.V600E immunoperoxidase stain in FNA direct smears and cell block preparations from patients with thyroid carcinoma. Cancer Cytopathol 126(6):406-413, 2018. e-Pub 2018. PMID: 29579361.
125. Keung EZ, Ikoma N, Benjamin R, Wang WL, Lazar AJ, Feig BW. The clinical behavior of well differentiated liposarcoma can be extremely variable: A retrospective cohort study at a major sarcoma center. J Surg Oncol 117(8):1799-1805, 2018. e-Pub 2018. PMID: 29723411.
126. Kim G, Kurnit K, Djordjevic B, Singh C, Munsell M, Wang WL, Lazar A, Broaddus R. Nuclear β-Catenin Localization and Mutation of the CTNNB1 Gene: A Context-Dependent Association. Mod Pathol. e-Pub 2018.
127. Beird HC, Wu CC, Ingram DR, Wang WL, Alimohamed A, Gumbs C, Little L, Song X, Feig BW, Roland CL, Zhang J, Benjamin RS, Hwu P, Lazar AJ, Futreal PA, Somaiah N. Genomic profiling of dedifferentiated liposarcoma compared to matched well-differentiated liposarcoma reveals higher genomic complexity and a common origin. Cold Spring Harb Mol Case Stud 4(2), 2018. e-Pub 2018. PMID: 29610390.
128. Frezza AM, Jones RJ, Vullo SL, Asano N, Lucibello F, Eytan B, Ratan R, Teterycz P, Boye K, Brhami M, Palmerini E, Fedenko A, Bincenzi B, Brunello A, Desar IME, Benjmain RS, Blay JY, Broto JM, Casali PG, Gelderblom H, Grignani G, Gronchi A, Hall KS, Mir O, Rutkowski P, Wagner AJ, Anurova O, Collini P, Dei Tos AP, Flucke U, Hornick J, Lobmaier I, Philippe T, Picci P, Ranchere D, Renne S, Sbaraglia M, Thyway K, Wagrodzki M, Wang WL, Akihiko Y, Mariani L, Kawai A, Stacchiotti S. Anthracycline, gemcitabine and pazopanib in epithelioid sarcoma: results of a retrospective multi-institutional case series. JAMA. e-Pub 2018.
129. Roland CL, Bednarski BK, Watson K, Torres KE, Cormier JN, Wang WL, Lazar AJ, Somaiah N, Hunt KK, Feig BW. Identification of preoperative factors associated with outcomes following surgical management of intra-abdominal recurrent or metastatic GIST following neoadjuvant tyrosine kinase inhibitor therapy. J Surg Oncol 117(5):879-885, 2018. e-Pub 2018. PMID: 29448300.
130. Somaiah N, Beird H, Barbo A, Song J, Shaw K, Wang WL, Eterovic A, Chen K, Lazar AJ, Conley A, Ravi V, Hwu P, Futreal A, Simon G, Meric-Bernstam F, Hong D. Targeted next generation sequencing of well-differentiated/dedifferentiated liposarcoma reveals novel gene amplifications and mutations. Oncotarget 9(28):19891-19899, 2018. e-Pub 2018. PMID: 29731991.
131. Beird HC, Wu CC, Ingram DR, Wang WL, Alimohamed A, Gumbs C, Little L, Song X, Feig BW, Roland CL, Zhang J, Benjamin RS, Hwu P, Lazar AJ, Futreal PA, Somaiah N. Genomic profiling of dedifferentiated liposarcoma compared to matched well-differentiated liposarcoma reveals higher genomic complexity and a common origin. Cold Spring Harb Mol Case Stud 4(2), 2018. e-Pub 2018.
132. Mauzo SH, Milton DR, Prieto VG, Torres-Cabala CA, Wang WL, Chakravarti N, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Brown RE, Aung PP. Summary of expression of SPARC protein in cutaneous vascular neoplasms and mimickers. Ann Diagn Pathol 34:151-154, 2018. e-Pub 2018. PMID: 29660567.
133. Smith A, Williams M, Steward J, Wang WL, Krishnamurthy S, Cabanillas M, Roy-Chowduri S. Utility of BRAF p.V600E Immunoperoxidase Stain in Fine Needle Aspiration Direct Smears and Cell Block Preparations from Thyroid Carcinoma Patients. Cancer Cytopathology. e-Pub 2018.
134. AUC Task Force AUC, Vidal CI, Armbrect EA, Andea AA, Bohlke AK, Comfere NI, Hughes SR, Kim J, Kozel JA, Lee JB, Linos K, Litzner BR, Missall TA, Novoa RA, Sundram U, Swick BL, Rating Panel YHM, Alam M, Argenyi Z, Duncan LM, Elston DM, Emanuel PO, Ferringer T, Fung MA, Hosler GA, Lazar AJ, Lowe L, Plaza JA, Prieto VG, Robinson JK, Schaffer A, Subtil A, Wang W. Appropriate Use Criteria in Dermatopathology: Initial Recommendations from the American Society of Dermatopathology. J Cutan Pathol. e-Pub 2018. PMID: 29566273.
135. Beaino ME, Roszik J, Livingston JA, Wang WL, Lazar AJ, Amini B, Subbiah V, Lewis V, Conley AP. Mesenchymal Chondrosarcoma: a Review with Emphasis on Fusion-Driven Biology. Current Oncology Reports 20(37). e-Pub 2018.
136. Noll B, Wang WL, Gong Y, Zhao J, Kalhor N, Staerkel G, Roy-Chowdhuri S. Programmed Death-Ligand 1 (PD-L1) Testing in Non-Small Cell Lung Carcinoma Cytology Preparations of Cell Block and Aspirate Smears. Cancer Cytopathology. e-Pub 2018. PMID: 29499101.
137. Feasel P, Al-Ibraheemi A, Fritchie K, Zriek RT, Wang WL, Demicco E, Saeb-Lima M, Golblum JR, Rubin BP, McKenney JK, Ko JS, Billings SD. Superficial Solitary Fibrous Tumors: A Series of 26 Cases. Am J Surg Pathol. e-Pub 2018. PMID: 29438169.
138. Ali A, Wang WL, Lazar AJ. Primary Chondro-osseous melanoma (Chondrosarcomatous & Osteosarcomatous Melanoma). Journal of Cutaneous Pathology 45(2):146-150, 2018. e-Pub 2018.
139. Roland CL, Bednarski BK, Watson K, Torres KE, Cormier JN, Wang WL, Lazar AJ, Somaiah N, Hunt KK, Feig BW. Identification of Preoperative Factors Associated with Outcomes Following Surgical Management Intra-abdominal Recurrent or Metastatic GIST Following Neoadjuvant Tyrosine Kinase Inhibitor Therapy. Journal of Surgical Oncology. e-Pub 2018.
140. Ali AM, Wang WL, Lazar AJ. Primary chondro-osseous melanoma (chondrosarcomatous and osteosarcomatous melanoma). J Cutan Pathol 45(2):146-150, 2018. e-Pub 2018. PMID: 29068062.
141. Demicco EG, Wani K, Ingram D, Wagner M, Maki RG, Rizzo A, Meeker A, Lazar AJ, Wang WL. TERT Promoter Mutations in Solitary Fibrous Tumor. Histopathology 73(5):843-851, 2018. e-Pub 2018.
142. Oba J, Kim SH, Wang WL, Macedo MP, Carapeto F, McKean MA, Van Arnam J, Eterovic AK, Sen S, Kale CR, Yu X, Haymaker CL, Routbort M, Haydu LE, Bernatchez C, Lazar AJ, Grimm EA, Hong DS, Woodman SE. Targeting the HGF/MET Axis Counters Primary Resistance to KIT Inhibition in KIT-Mutant Melanoma. JCO Precis Oncol 2018, 2018. e-Pub 2018. PMID: 30094412.
143. Murai NO, Teniola O, Wang WL, Amini B. Bone and Soft Tissue Tumors About the Foot and Ankle. Radiologic Clinics of North America 56(6):917-934, 2018. e-Pub 2018. PMID: 30322490.
144. Conley AP, Trinh VA, Zobniw CM, Posey K, Martinez JD, Arrieta OG, Wang WL, Roszik J, Patel SR. Positive Tumor Response to Combined Checkpoint Inhibitors in a Patient with Refractory Alveolar Soft Part Sarcoma: A Case report. Journal of Global Oncology(4):1-6, 2018. e-Pub 2018.
145. Ikoma N, Roland CL, Torres KE, Y-J C, W-L W, Somaiah N, Mann G, Hunt KK, Cormier J, Feig B. Concomitant Organ Resection Does Not Improve Outcomes in Primary Retroperitoneal Well-Differentiated Liposarcoma: A Retrospective Cohort Study at a Major Sarcoma Center. Journal of Surgical Oncology. e-Pub 2017. PMID: 29228466.
146. Teniola O, Wang K, Wang WL, Tseng W, Behrang A. Imaging of Liposarcomas: Characteristic Features and Differential Considerations. Journal of Surgical Oncology. e-Pub 2017. PMID: 29228461.
147. May CD, Landers SM, Bolshakov S, Ma X, Ingram DR, Kivlin CM, Watson KL, Sannaa GAA, Bhalla AD, Wang WL, Lazar AJ, Torres KE. Co-targeting PI3K, mTOR, and IGF1R with small molecule inhibitors for treating undifferentiated pleomorphic sarcoma. Cancer Biol Ther 18(10):816-826, 2017. e-Pub 2017. PMID: 29099264.
148. Keung EZ, Tsai JW, Ali Ali M, Cormier JN, Bishop AJ, Guadagnolo BA, Torres KE, Somaiah N, Hunt KK, Wargo JA, Lazar AJ, Wang WL, Roland CL. Analysis of the Immune Infiltrate in Undifferentiated Pleomorphic Sarcoma of the Extremity and Trunk in Response to Radiotherapy: Rationale for Combination Neoadjuvant Immune Checkpoint Inhibition and Radiotherapy. OncoImmunology 7(2), 2017. e-Pub 2017. PMID: 29308306.
149. Livingston JA, Bugano D, Barbo A, Lin H, Madewell JE, Wang WL, Lazar AJ, Tseng WW, Roland CL, Feig BW, Pollock R, Conley AP, Benjamin RS, Patel S, Somaiah N. Role of chemotherapy in dedifferentiated liposarcoma of the retroperitoneum: defining the benefit and challenges of the standard. Sci Rep 7(1):11836, 2017. e-Pub 2017. PMID: 28928422.
150. Schvartsman G, Wagner MJ, Amini B, Zobniw CM, Trinh VA, Barbo AG, Lin HY, Wang WL, Conley AP, Ravi V, Araujo DM, Zarzour MA, Benjamin RS, Patel S, Somaiah N. Treatment patterns, efficacy and toxicity of regorafenib in gastrointestinal stromal tumour patients. Sci Rep 7(1):9516, 2017. e-Pub 2017. PMID: 28842575.
151. Panse G, Chrisinger JSA, Leung CH, Ingram DR, Khan S, Wani K, Lin H, Lazar AJ, Wang WL. Clinicopathological analysis of ATRX, DAXX and NOTCH Receptor Expression in Angiosarcomas. Histopathology, 2017. e-Pub 2017. PMID: 28796347.
152. Khoury J, Wang WL, Prieto VG, Medeiros JL, Kalhor N, Hameed M, Broaddus R, Hamilton S. Validation of Immunohistochemical Assays for Integral Biomarkers in the NCI-MATCH EAY131 Clinical Trial. Clinical Cancer Research, 2017. e-Pub 2017. PMID: 28839110.
153. Staniago-O'Farrill J, Kleinerman E, Hollomon M, Livingston A, Wang WL, Tsai JW, Gordon N. Phosphorylated heat shock protein 27 as a potential biomarker to predict the role of chemotherapy-induced autophagy in ostosarcoma response to therapy. Oncotarget 9(2):1602-1616, 2017. e-Pub 2017. PMID: 29416717.
154. Wagner MJ, Gopalakrishnan V, Ravi V, Livingston JA, Conley AP, Araujo D, Somaiah N, Zarzour MA, Ratan R, Wang WL, Patel SR, Lazar A, Ludwig JA, Benjamin RS. Vincristine, Ifosfamide, and Doxorubicin for Initial Treatment of Ewing Sarcoma in Adults. Oncologist, 2017. e-Pub 2017. PMID: 28710342.
155. Demicco EG, Wagner M, Maki RG, Gupta V, Iofin I, Lazar AJ, Wang WL. Risk Assessment in Solitary Fibrous Tumors: Validation and Refinement of a Risk Stratification Model. Mod Pathol, 2017. e-Pub 2017. PMID: 28731041.
156. Kumar R, Duran C, Amini B, Araujo DM, Wang WL. Periosteal mesenchymal chondrosarcoma of the tibia with multifocal bone metastaste: a case report. Skeletal Radiol 46(7):995-1000, 2017. e-Pub 2017. PMID: 28352960.
157. Patel NR, Chrisinger JSA, Demicco EG, Sarabia SF, Reuther J, Kumar E, Oliveriera AM, Billings SD, JVMG B, Roy A, Lazar AJ, Lopez-Terrada DH, Wang WL. USP6 Activation in Nodular Fasciitis by Promoter-Swapping Gene Fusions. Mod Pathol, 2017. e-Pub 2017. PMID: 28752842.
158. Satcher RL, Ravi V, Wang WL, Oates S. Postpartum Treatment of Metastatic Recurrent Giant Cell Tumor of Capitate Bone of Wrist. Am J Orthopedics 46(4), 2017. e-Pub 2017. PMID: 28856360.
159. Livingston JA, Wang WL, J-W T, aJ L, Leung CH, Lin HY, Advani SM, Daw N, Santiago-O'Farrill J, Hollomon M, Gordon N, Kleinerman ES. Analysis of HSP27 and the autophagy marker LC3B+ puncta following preoperative chemotherapy identifies high-risk osteosarcoma patients. Molecular Cancer Therapeutics 17(6):1315-1323, 2017. e-Pub 2017. PMID: 29592877.
160. Charville G, Wang WL, Ingram D, Roy A, Thomas D, Patel R, Hornick J, van de Rijn M, Lazar AJ. EWSR1 fusion proteins mediate PAX7 expression in Ewing Sarcoma. Mod Pathol. e-Pub 2017. PMID: 28643791.
161. Roszik J, Wang WL, Livingston JA, Roland CL, Ravi V, Yee C, Hwu P, Futreal A, Lazar AJ, Patel SR, Conley AP. Overexpressed PRAME is a potential immunotherapy target in sarcoma subtypes. Clinical Sarcoma Research, 2017. e-Pub 2017. PMID: 28630682.
162. Panse G, Leung CH, Ingram D, Wani K, Torres KE, Lin H, Lazar AJ, Wang WL. The Role of Phosphorylated Signal Transducer and Activator of Transcription 3 (pSTAT3) in Peripheral Nerve Sheath Tumors. Histopathology 70(6):946-953, 2017. e-Pub 2017. PMID: 27992966.
163. Leon-Castillo A, Chrisinger JSA, Panse G, Samdani RT, Prieto VG, Wang WL, Lazar AJ. Index report of cutaneous angiosarcoma with strong positivity for tryosinase mimicking melanoma with further evaluation of melanocytic markers in a large angiosarcoma series. Journal of Cutaneous Pathology. e-Pub 2017. PMID: 28556023.
164. Qin Y, Petaccia de Macedo M, Reuben A, Forget MA, Haymaker C, Bernatchez C, Spencer CN, Gopalakrishnan V, Reddy S, Cooper ZA, Fulbright OJ, Ramachandran R, Wahl A, Flores E, Thorsen ST, Tavera RJ, Conrad C, Williams MD, Tetzlaff MT, Wang WL, Gombos DS, Esmaeli B, Amaria RN, Hwu P, Wargo JA, Lazar AJ, Patel SP. Parallel profiling of immune infiltrate subsets in uveal melanoma versus cutaneous melanoma unveils similarities and differences: A pilot study. Oncoimmunology 6(6), 2017. e-Pub 2017. PMID: 28680759.
165. Farag S, Somaiah N, Choi H, Heeres B, Wang WL, van Boven H, Nederlof P, Benjamin R, van der Graaf W, Grunhagen D, Boonstra PA, Reyners AK, Gelderblom H, Steeghs N. Clinical characteristics and treatment outcome in a large multicentre observational cohort of PDGFRA exon 18 mutated gastrointestinal stromal tumour patients. Eur J Cancer 76:76-83, 2017. e-Pub 2017. PMID: 28284172.
166. Oba J, Esmaeli B, Ellerhorst JA, Lyons GR, Milton DR, Wang WL, Macedo MP, Lazar AJ, Grimm EA, Chattopadhyay C. Trends in hepatocyte growth factor, insulin-like growth factor 1, thyroid-stimulating hormone, and leptin expression levels in uveal melanoma patient serum and tumor tissues: correlation to disease progression. Melanoma Res 27(2):126-133, 2017. e-Pub 2017. PMID: 28118269.
167. Oba J, Esmaeli B, Ellerhorst JA, Lyons GR, Miltron DR, Wang WL, Macedo MP, Lazar AJ, Grimm EA, Chattopadhyay C. Trends in hepatocyte growth factor, insulin-like growth factor 1, thyroid-stimulating hormone, and leptin expression levels in uveal melanoma p atient serum and tumor tissues: correlation to disease progression. Melanoma Research 27(2):126-133, 2017. e-Pub 2017.
168. Farag S, Somaiah N, Choi H, Heeres B, Wang WL, van Boven H, Nederlof P, Benjamin R, van der Graaf W, Grunhagen D, Boonstra P, Reyners AKL, Gelderblom H, Steeghs N. Clinical characteristics and treatment outcome in a large multicenter observational cohort of PDGFRA exon 18 mutated gastrointestinal stromal tumor (GIST) patients. European Journal of Cancer 76:76-83, 2017. e-Pub 2017.
169. McConnel M, Kumar R, Amini B, Lin PP, Wang WL. Calcified synovial metastasis in the knee from renal cell carcinoma: a case report. Skeletal Radiol 46(1):123-127, 2017. e-Pub 2017. PMID: 27761602.
170. Barrott JJ, Kafchinski LA, Jin H, Potter JW, Kannan SD, Kennedy R, Mosbruger T, Wang WL, Tsai JW, Araujo DM, Liu T, Capecchi MR, Lazar AJ, Jones KB. Modeling synovial sarcoma metastasis in the mouse: PI3'-lipid signaling and inflammation. J Exp Med 213(13):2989-3005, 2016. e-Pub 2016. PMID: 27956588.
171. Barrott JJ, Kafchinski LA, in H, Potter JW, Kannan S, Kennedy R, Mosbruger T, Wang WL, Tsai JW, Araujo DM, Liu T, Capecchi MR, Lazar AJ. Modeling synovial sarcoma metastasis in the mouse: PI3'-lipid signaling and inflammation. Journal of Experimental Medicine 213(13):2989-3005, 2016. e-Pub 2016.
172. Kumar E, Patel NR, Demicco EG, Bovee JV, Olivera AM, Lopez-Terrada DH, Billings SD, Lazar AJ, Wang WL. Cutaneous Nodular Fasciitis with Genetic Analysis: A Case Series. Journal of Cutaneous Pathology 43(12):1143-1149, 2016. e-Pub 2016.
173. Al Sanna G, Watson KL, Olar A, Wang WL, Fuller GN, McCuthceon I, Torres KE, Lazar AJ. Sarcoma Brain Metastases: 28 years of Experience at a Single Institution. Annals of Surgical Oncology 23(Suppl 5):962-967, 2016. e-Pub 2016.
174. Kumar E, Patel NR, Demicco EG, Bovee JV, Olivera AM, Lopez-Terrada DH, Billings SD, Lazar AJ, Wang WL. Cutaneous nodular fasciitis with genetic analysis: a case series. J Cutan Pathol 43(12):1143-1149, 2016. e-Pub 2016. PMID: 27686647.
175. Al Sannaa G, Watson KL, Olar A, Wang WL, Fuller GN, McCutcheon I, Torres KE, Lazar AJ. Sarcoma Brain Metastases: 28 Years of Experience at a Single Institution. Ann Surg Oncol 23(Suppl 5):962-967, 2016. e-Pub 2016. PMID: 27646022.
176. Nathenson MJ, Ravi V, Fleming N, Wang WL, Conley A. Uterine Adenosarcoma: a Review. Curr Oncol Rep 18(11):68, 2016. e-Pub 2016. PMID: 27718181.
177. Subbiah V, Holmes O, Gowen K, Spritz D, Amini B, Wang WL, Schrock AB, Meric-Bernstam F, Zinner R, Piha-Paul S, Zarzour M, Elvin JA, Erlich RL, Stockman DL, Vergilio JA, Suh JH, Stephens PJ, Miller V, Ross JS, Ali SM. Activity of c-Met/ALK Inhibitor Crizotinib and Multi-Kinase VEGF Inhibitor Pazopanib in Metastatic Gastrointestinal Neuroectodermal Tumor Harboring EWSR1-CREB1 Fusion. Oncology 91(6):348-353. e-Pub 2016. PMID: 27764830.
178. Bird JE, Morse LJ, Feng L, Wang WL, Lin PP, Moon BS, Lazar AJ, Satcher RL, Madewell JE, Lewis VO. Non-Radiographic Risk Factors Differentiating Atypical Lipomatous Tumors from Lipomas. Front Oncol 6:197, 2016. e-Pub 2016. PMID: 27713864.
179. Bettegowda C, Yip S, Lo S-F L, Fischer CG, Boriani S, Rhines LD, Wang JY, Lazary A, Gambarotti M, W-L W, Luzzati A, Dekutoski MB, Bilsky MH, Chou D, Felings MG, McCarthy EF, Quraishi NA, Reynolds JJ, Scuibba DM, Williams RP, Wolinksy JP, Zadnik PL, Zhang M, Germschied NM, Kalampoli V, Varga PP, Gokaslan ZL. Spinal column chordoma: prognostic significance of clinical variables and T (brachyury) gene SNP rs2305089 for local recurrence and overall survival. Neuro-Oncology, 2016. e-Pub 2016. PMID: 27663388.
180. Cleven AH, Al Sannaa GA, Briaire-de Bruijn I, Ingram DR, van de Rijn M, Rubin BP, de Vries MW, Watson KL, Torres KE, Wang WL, van Duinen SG, Hogendoorn PC, Lazar AJ, Bovée JV. Loss of H3K27 tri-methylation is a diagnostic marker for malignant peripheral nerve sheath tumors and an indicator for an inferior survival. Mod Pathol 29(9):1113, 2016. e-Pub 2016. PMID: 27573709.
181. Roland CL, May CD, Watson KL, Al Sannaa GA, Dineen SP, Feig R, Landers S, Ingram DR, W-L W, Guadagnolo BA, Feig B, Hunt KK, Cormier JN, Lazar AJ, Torres KE. Analysis of Clinical and Molecular Factors Impacting Oncologic Outcomes in Undifferentiated Pleomorphic Sarcoma. Annals of Surgical Oncology 23(7):2220-8, 2016. e-Pub 2016. PMID: 26847678.
182. Loghavi S, Routbort MJ, Patel KP, Luthra R, Wang WL, Broaddus RR, Davies MA, Lazar AJ. How Do We Make Clinical Molecular Testing for Cancer Standard of Care for Pathology Departments?. J Natl Compr Canc Netw 14(6):787-92, 2016. e-Pub 2016. PMID: 27283170.
183. Cleven AH, Sannaa GA, Briaire-de Bruijn I, Ingram DR, van de Rijn M, Rubin BP, de Vries MW, Watson KL, Torres KE, Wang WL, van Duinen SG, Hogendoorn PC, Lazar AJ, Bovee JV. Loss of H3K27 tri-methylation is a diagnostic marker for malignant peripheral nerve sheath tumors and an indicator for an inferior survival. Mod Pathol 29(6):582-90, 2016. e-Pub 2016. PMID: 26990975.
184. Ravi V, Sanford EM, Wang WL, Ross JS, Ramesh N, Futreal A, Patel S, Stephens PJ, Miller VA, Ali SM. Antitumor Response of VEGFR2- and VEGFR3-Amplified Angiosarcoma to Pazopanib. J Natl Compr Canc Netw 14(5):499-502, 2016. e-Pub 2016. PMID: 27160228.
185. Watson KL, Al Sannaa G, Kivlin CM, Ingram DR, Landers SM, Roland CL, Cormier JN, Hunt KK, Feig BW, Guadagnolo BA, Bishop AJ, Wang WL, Slopis JM, McCutcheon IE, Lazar AJ, Torres KE. Patterns of recurrence and survival in sporadic, neurofibromatosis type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors (MPNSTs). Journal of Neurosurgery:1-11, 2016. e-Pub 2016. PMID: 27035165.
186. Roland CL, Boland GM, Demicco EG, Lusby K, Ingram D, May CD, Kivlin CM, Watson K, Al Sannaa GA, Wang WL, Ravi V, Pollock RE, Lev D, Cormier JN, Hunt KK, Feig BW, Lazar AJ, Torres KE. Clinical Observations and Molecular Variables of Primary Vascular Leiomyosarcoma. JAMA Surg 151(4):347-354, 2016. e-Pub 2016. PMID: 26629783.
187. Yedururi S, Morani AC, Gladish GW, Vallabhaneni S, Anderson PM, Hughes D, Wang WL, Daw NC. Cardiovascular involvement by osteosarcoma: an analysis of 20 patients. Pediatr Radiol 46(1):21-33, 2016. e-Pub 2016. PMID: 26411434.
188. Kamali F, Wang WL, Guadagnolo BA, Fox PS, Lewis VO, Lazar AJ, Conley AP, Ravi V, Toliyat M, Ladha HS, Hobbs BP, Amini B. MRI can be used as a prognostic indicator in patients with desmoid fibromatosis. British Journal of Radiology 89(1058), 2016. e-Pub 2016. PMID: 26577289.
189. Dineen SP, Roland CL, Feig R, May C, Zhou S, Demicco E, Sannaa GA, Ingram D, Wang WL, Ravi V, Guadagnolo A, Lev D, Pollock RE, Hunt K, Cormier J, Lazar A, Feig B, Torres KE. Radiation-Associated Undifferentiated Pleomorphic Sarcoma is Associated with Worse Clinical Outcomes than Sporadic Lesions. Ann Surg Oncol 22(12):3913-20, 2015. e-Pub 2015. PMID: 25743327.
190. Patel NR, Salim AA, Sayeed H, Sarabia SF, Hollingsworth F, Warren M, Jakacky J, Tanas M, Oliveira AM, Rubin BP, Lazar AJ, López-Terrada D, Wang WL. Molecular Characterization of Epithelioid Haemangioendotheliomas Identifies Novel WWTR1-CAMTA1 Fusion Variants. Histopathology 67(5):699-708, 2015. e-Pub 2015. PMID: 25817592.
191. Bishop AJ, Zagars GK, Demicco EG, Wang W, Feig BW, Guadagnolo BA. Soft tissue solitary fibrous tumor: combined surgery and radiation therapy results in excellent local control. American Journal of Clinical Oncology. e-Pub 2015. PMID: 26270446.
192. Demicco EG, Wani K, Fox PS, Bassett RL, Young ED, Lev D, Aldape KD, Lazar AJ, Wang WL. Histologic Variability in Solitary Fibrous Tumors Reflects Angiogenic and Growth Factor Signaling Pathway Alterations. Hum Pathol 46(7):1015-26, 2015. e-Pub 2015. PMID: 25976141.
193. Wang WL, Torres-Cabala C, Curry JL, Ivan D, McLemore M, Tetzlaff M, Zembowicz A, Prieto VG, Lazar AJ. Metastatic atypical fibroxanthoma: A series of 11 caes including with minimal and no subcutaneous involvement. Am J Dermatopathol 37(6):455-61, 2015. e-Pub 2015. PMID: 25590287.
194. Demicco EG, Harms PW, Patel RM, Smith SC, Ingram D, Torres K, Carskadon SL, Camelo-Piragua S, McHugh JB, Siddiqui J, Palanisamy N, Lucas DR, Lazar AJ, Wang WL. Extensive survey of STAT6 expression in a large series of mesenchymal tumors. Am J Clin Pathol 143(5):672-82, 2015. e-Pub 2015. PMID: 25873501.
195. Ikoma N, Torres KE, Somaiah N, Hunt KK, Cormier JN, Tseng W, Lev D, Pollock R, Wang WL, Feig B. Accuracy of preoperative percutaneous biopsy for the diagnosis of retroperitoneal liposarcoma subtypes. Ann Surg Oncol 22(4):1068-72, 2015. e-Pub 2015. PMID: 25354575.
196. Demicco EG, Boland GM, Brewer Savannah KJ, Lusby K, Young ED, Ingram D, Watson KL, Bailey M, Guo X, Hornick JL, van de Rijn M, Wang WL, Torres KE, Lev D, Lazar AJ. Progressive Loss Of Myogenic Differentiation In Leiomyosarcoma Has Prognostic Value. Histopathology 66(5):627-38, 2015. e-Pub 2015. PMID: 24889065.
197. Pan HY, Morani A, Wang WL, Hess KR, Paulino AC, Ludwig JA, Lin PP, Daw NC, Mahajan A. Prognostic Factors and Patterns of Relapse in Ewing Sarcoma Patients Treated With Chemotherapy and R0 Resection. Int J Radiat Oncol Biol Phys. e-Pub 2015. PMID: 25772182.
198. Merritt H, Yin VT, Pfeiffer ML, W-L W, Sniegowski MC, Esmaeli B. Treatment Challenges with Benign Bone Tumors of the Orbit. Ocul Oncol Pathol 2015 1(2):111-120, 2015. e-Pub 2015.
199. Merritt H, Yin VT, Pfeiffer ML, Wang WL, Sniegowski MC, Esmaeli B. Treatment Challenges with Benign Bone Tumors of the Orbit. Ocul Oncol Pathol 1(2):111-20, 2015. e-Pub 2015. PMID: 27171013.
200. Siroy AE, Boland GM, Milton DR, Roszik J, Frankian S, Malke J, Haydu L, Prieto VG, Tetzlaff M, Ivan D, Wang WL, Torres-Cabala C, Curry J, Roy-Chowdhuri S, Broaddus R, Rashid A, Stewart J, Gershenwald JE, Amaria RN, Patel SP, Papadopoulos NE, Bedikian A, Hwu WJ, Hwu P, Diab A, Woodman SE, Aldape KD, Luthra R, Patel KP, Shaw KR, Mills GB, Mendelsohn J, Meric-Bernstam F, Kim KB, Routbort MJ, Lazar AJ, Davies MA. Beyond BRAF V600: clinical mutation panel testing by next-generation sequencing in advanced melanoma. J Invest Dermatol 135(2):508-15, 2015. e-Pub 2015. PMID: 25148578.
201. May CD, Garnett J, Ma X, Landers SM, Ingram DR, Demicco EG, Al Sannaa GA, Vu T, Han L, Zhang Y, Kivlin CM, Bolshakov S, Kalam AA, Liu J, Zhou F, Broccoli D, Wang WL, Lazar AJ, Pollock RE, Lev D, Torres KE. AXL is a potential therapeutic target in dedifferentiated and pleomorphic liposarcomas. BMC Cancer 15(1):901, 2015. e-Pub 2015. PMID: 26573603.
202. Joseph J, Wang WL, Patnana M, Ramesh N, Benjamin R, Patel S, Ravi V. Cytotoxic and targeted therapy for treatment of pseudomyogenic hemangioendothelioma. Clin Sarcoma Res 5:22, 2015. e-Pub 2015. PMID: 26500758.
203. Peters TL, Kuma V, Polikepahad S, Lin FY, Sarabia SF, Liang Y, Wang WL, Lazar AJ, Doddapaneni HV, Choa H, Muzny DM, Wheeler DA, Okcu MF, Plon SE, Hickes MJ, Lopez-Terrada D, Parsons DW, Roy A. BCOR-CCNB3 Fusions are Frequent in Undifferentiated Sarcoma of Male Children. Mod Pathol 28:575-586, 2015. e-Pub 2015. PMID: 25360585.
204. Yorio JT, Mays SR, Ciurea AM, Cohen PR, Wang WL, Hwu WJ, Gonzalez N, Richard JL, Kim KB. Case of vemurafenib-induced Sweet's syndrome. J Dermatol, 2014. e-Pub 2014. PMID: 24617955.
205. Stockman DL, Hornick JL, Deavers MT, Lev DC, Lazar AJ, Wang WL. ERG and FLI1 protein expression in epithelioid sarcoma. Mod Pathol 27(4):496-501, 2014. e-Pub 2014. PMID: 24072183.
206. Guma SR, Lee DA, Yu L, Gordon N, Hughes D, Stewart J, Wang WL, Kleinerman ES. Natural killer cell therapy and aerosol interleukin-2 for the treatment of osteosarcoma lung metastasis. Pediatr Blood Cancer 61(4):618-26, 2014. e-Pub 2014. PMID: 24136885.
207. Sasaki K, Pemmaraju N, Westin JR, Wang WL, Khoury JD, Podoloff DA, Moon B, Daver N, Borthakur G. A Single Case of Rosai-Dorfman Disease Marked by Pathologic Fractures, Kidney Failure, and Liver Cirrhosis Treated with Single-Agent Cladribine. Front Oncol 4:297, 2014. e-Pub 2014. PMID: 25401088.
208. Subbiah V, Westin SN, Wang K, Araujo D, Wang WL, Miller VA, Ross JS, Stephens PJ, Palmer GA, Ali SM. Targeted therapy by combined inhibition of the RAF and mTOR kinases in malignant spindle cell neoplasm harboring the KIAA1549-BRAF fusion protein. J Hematol Oncol 7(1):8, 2014. e-Pub 2014. PMID: 24422672.
209. Tetzlaff MT, Wang WL, Milless TL, Curry JL, Torres-Cabala CA, McLemore MS, Ivan D, Bassett RL, Prieto VG. Ambiguous melanocytic tumors in a tertiary referral center: the contribution of fluorescence in situ hybridization (FISH) to conventional histopathologic and immunophenotypic analyses. Am J Surg Pathol 37(12):1783-96, 2013. e-Pub 2013. PMID: 24061523.
210. Tetzlaff MT, Curry JL, Ivan D, Wang WL, Torres-Cabala CA, Bassett RL, Valencia KM, McLemore MS, Ross MI, Prieto VG. Immunodetection of phosphohistone H3 as a surrogate of mitotic figure count and clinical outcome in cutaneous melanoma. Mod Pathol 26(9):1153-60, 2013. e-Pub 2013. PMID: 23558574.
211. Hoffman A, Ghadimi MP, Demicco EG, Creighton CJ, Torres K, Colombo C, Peng T, Lusby K, Ingram D, Hornick JL, Wang WL, Ravi V, Lazar AJ, Lev D, Pollock RE. Localized and metastatic myxoid/round cell liposarcoma: clinical and molecular observations. Cancer 119(10):1868-77, 2013. e-Pub 2013. PMID: 23401071.
212. Demicco EG, Wang WL, Madewell JE, Huang D, Bui MM, Bridge JA, Meis JM. Osseous myxochondroid sarcoma: a detailed study of 5 cases of extraskeletal myxoid chondrosarcoma of the bone. Am J Surg Pathol 37(5):752-62, 2013. e-Pub 2013. PMID: 23588370.
213. Al-Zaid T, Wang WL, Lopez-Terrada D, Lev D, Hornick JL, Hafeez Diwan A, Fletcher CD, Lazar AJ. Pleomorphic fibroma and dermal atypical lipomatous tumor: are they related?. J Cutan Pathol 40(4):379-84, 2013. e-Pub 2013. PMID: 23506010.
214. Lim D, Wang WL, Lee CH, Dodge T, Gilks B, Oliva E. Old versus new FIGO staging systems in predicting overall survival in patients with uterine leiomyosarcoma: a study of 86 cases. Gynecol Oncol 128(2):322-6, 2013. e-Pub 2013. PMID: 23153591.
215. Park MS, Ravi V, Conley A, Patel SR, Trent JC, Lev DC, Lazar AJ, Wang WL, Benjamin RS, Araujo DM. The role of chemotherapy in advanced solitary fibrous tumors: a retrospective analysis. Clin Sarcoma Res 3(1):7, 2013. e-Pub 2013. PMID: 23663788.
216. Chu VH, Tetzlaff MT, Torres-Cabala CA, Prieto VG, Bassett R, Gershenwald JE, McLemore MS, Ivan D, Wang WL, Ross MI, Curry JL. Impact of the 2009 (7th edition) AJCC melanoma staging system in the classification of thin cutaneous melanomas. Biomed Res Int 2013:898719, 2013. e-Pub 2013. PMID: 24369020.
217. Suchak R, Wang WL, Prieto VG, Ivan D, Lazar AJ, Brenn T, Calonje E. Cutaneous Digital Papillary Adenocarcinoma: A Clinicopathological Study of 31 Cases of a Rare Neoplasm with New Observations. Am J Surg Path, 2012. e-Pub 2012. PMID: 23026931.
218. Wang WL, Katz D, Araujo D, Ludwig JA, Trent JC, Patel SR, Lin PP, Guadagnolo A, Lopez-Terrada D, dei Tos AP, Lewis VO, Lev DC, Pollok RE, Zagars GK, Benjamin RS, Madewell JE, Lazar AJ. Extensive Adipocytic Maturation Can Be Seen in Myxoid Liposarcomas Treated with Neoadjuvant Doxorubicin and Ifosfamide and Pre-Operative Radiation Therapy. Clinical Sarcoma Research 2(1):25, 2012. e-Pub 2012. PMID: 23272660.
219. Doyle LA, Wang WL, Dal Cin P, Lopez-Terrada D, Mertens F, Lazar AJ, Fletcher CD, Hornick JL. MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement. Am J Surg Pathol 36(10):1444-51, 2012. e-Pub 2012. PMID: 22982887.
220. Wang WL, Nero C, Pappo A, Lev D, Lazar AJ, López-Terrada D. CTNNB1 genotyping and APC Screening in Pediatric Desmoid Tumors: A Proposed Algorithm. Pediatr Dev Pathol 15(5):361-7, 2012. e-Pub 2012. PMID: 22372443.
221. Rozas-Munoz E, Martinez Escala ME, Wang WL, Ciurea AM, Pujol RM, Prieto VG. A slowly growing plaque on the lower back: challenge. Am J Dermatopathol 34(4):423; discussion 452-3, 2012. e-Pub 2012. PMID: 22317885.
222. Demicco EG, Park MS, Araujo DM, Fox PS, Bassett RL, Pollock RE, Lazar AJ, Wang WL. Solitary Fibrous Tumor: A Clinicopathological study of 110 cases and Novel Risk Assessment Model. Mod Pathol 25(9):1298-1306, 2012. e-Pub 2012. PMID: 22575866.
223. Rozas-Muñoz E, Martinez Escala ME, Wang WL, Ciurea AM, Pujol RM, Prieto VG. A Slowly Growing Plaque on the Lower Back: Answer. Am J Dermatopathol 34(4):428-433, 2012. e-Pub 2012. PMID: 22421293.
224. Wang WL, Evans HL, Meis JM, Liegl-Atzwanger B, Bovee JV, Goldblum JR, Billings SD, Rubin BP, López-Terrada D, Lazar AJ. FUS Rearrangements are Rare in "Pure" Sclerosing Epithelioid Fibrosarcoma. Mod Pathol 25(6):846-853, 2012. e-Pub 2012. PMID: 22388756.
225. Patel JN, Wang WL, Murphy WA. Painful Left Shoulder. Skeletal Radiol 41(11):1489-1490, 2012. e-Pub 2012. PMID: 22127343.
226. Wang WL, Bones-Valentin RA, Prieto VG, Pollock RE, Lev DC, Lazar AJ. Sarcoma metastases to the skin: A clinicopathologic study of 65 patients. Cancer 118(11):2900-2904, 2012. e-Pub 2012. PMID: 21989966.
227. Demicco EG, Torres KE, Ghadimi MP, Colombo C, Bolshakov S, Hoffman A, Peng T, Bovée JV, Wang WL, Lev D, Lazar AJ. Involvement of the PI3K/Akt pathway in myxoid/round cell liposarcoma. Mod Pathol 25(2):212-212, 2012. e-Pub 2012. PMID: 22020193.
228. Zhang HY, Wang WL, Rapini RP, Torres-Cabala C, Prieto VG, Curry JL. Syringocytadenocarcinoma papilliferum with transition to areas of squamous differentiation: A case report and review of the literature. Am J Dermpath 38(10):818-822, 2012. e-Pub 2012. PMID: 22343110.
229. Al-Zaid T, Ditelberg JS, Prieto VG, Lev D, Luthra R, Davies MA, Diwan AH, Wang WL, Lazar AJ. Trichilememmoma show loss of PTEN in Cowden Syndrome but only rarely in sporadic tumors. J Cutan Pathol 39(5):493-499, 2012. e-Pub 2012. PMID: 22486434.
230. Katz D, Boonsirikamchai P, Choi H, Lazar AJ, Wang WL, Xiao L, Park MS, Ravi V, Benjamin RS, Araujo DM. Efficacy of first-line doxorubicin and ifosfamide in myxoid liposarcoma. Clin Sarcoma Res 2(1):2, 2012. e-Pub 2012. PMID: 22587772.
231. Bird J, Wang WL, Deaver MT, Madewell JE, Lewis VO. Enchondroma with secondary aneurysmal bone cyst. Skeletal Radiology 41(11):147-1478, 2012. e-Pub 2012. PMID: 22639202.
232. Wang WL, Patel NR, Caragea M, Hogendoorn P, Lopez-Terrada D, Hornick JL, Lazar AJ. Expression of Erg, an Ets Family Transcription Factor, Identifies ERG-rearranged Ewing Sarcoma. Mod Pathol 25(10):1378-1383, 2012. e-Pub 2012. PMID: 22766791.
233. Kriseman M, Wang WL, Sullinger J, Schmeler K, Ramirez P, Herzog C, Frumovitz MM. Rhabdomyosarcoma of the Cervix in Adult Women and Younger Patients. Gynecologic Oncology 126(3):351-356, 2012. e-Pub 2012. PMID: 22609112.
234. Doyle LA, Wang WL, Cin Dal P, Lopez-Terrada DL, Mertens F, Lazar AJ, Fletcher CDM, Hornick JL. Muc4 is a sensitive and specific marker for Sclerosing Epithelioid Fibrosarcoma: Association with FUS Gene Rearrangement. Am J Surg Pathol 36(10):14-1451, 2012. e-Pub 2012.
235. Huh WW, Yuen C, Munsell M, Hayes-Jordan A, Lazar AJ, Patel S, Wang WL, Barahmani N, Okcu MF, Hicks J, Debelenko L, Spunt SL. Liposarcoma in children and young adults: a multi-institutional experience. Pediatr Blood Cancer 57(7):1142-6, 2011. e-Pub 2011. PMID: 21394894.
236. Park MS, Patel SR, Ludwig JA, Trent JC, Conrad CA, Lazar AJ, Wang WL, Boonsirikamchai P, Choi H, Wang X, Benjamin RS, Araujo DM. Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor. Cancer 117(21):4939-47, 2011. e-Pub 2011. PMID: 21480200.
237. McLemore MS, Huo L, Deavers MT, Curry JL, Torres-Cabala CA, Wang WL, Prieto VG. Cutaneous epithelioid angiomatous nodule of the chest wall with expression of estrogen receptor: a mimic of carcinoma and a potential diagnostic pitfall. J Cutan Pathol 38(10):818-22, 2011. e-Pub 2011. PMID: 21752053.
238. Lahat G, Zhang P, Zhu QS, Torres K, Ghadimi M, Smith KD, Wang WL, Lazar AJ, Lev D. The expression of c-Met pathway components in unclassified pleomorphic sarcoma/malignant fibrous histiocytoma (UPS/MFH): a tissue microarray study. Histopathology 59(3):556-61, 2011. e-Pub 2011. PMID: 22034893.
239. Colombo C, Bolshakov S, Hajibashi S, Lopez-Terrada L, Wang WL, Rao P, Benjamin RS, Lazar AJ, Lev D. 'Difficult to diagnose' desmoid tumours: a potential role for CTNNB1 mutational analysis. Histopathology 59(2):336-40, 2011. e-Pub 2011. PMID: 21884214.
240. Dayrit JF, Wang WL, Goh SG, Ramdial PK, Lazar AJ, Calonje E. T-cell-rich angiomatoid polypoid pseudolymphoma of the skin: a clinicopathologic study of 17 cases and a proposed nomenclature. J Cutan Pathol 38(6):475-82, 2011. e-Pub 2011. PMID: 21352259.
241. Riddel CE, Surovik JG, Chon SY, Wang WL, Cho-Vega JH, Cutlan JE, Prieto VG. Fungal foes: presentations of chromoblastomycosis post-hurricane Ike. Cutis 87(6):269-72, 2011. e-Pub 2011. PMID: 21838080.
242. Swaby MG, Evans HL, Fletcher CD, Prieto VG, Patel KU, Lev DC, Lòpez-Terrada D, Lazar AJ, Wang WL. Dermatofibrosarcoma protuberans with unusual sarcomatous transformation: a series of 4 cases with molecular confirmation. Am J Dermatopathol 33(4):354-60, 2011. e-Pub 2011. PMID: 21478726.
243. Wang WL, Soslow R, Hensley M, Asad H, Zannoni GF, de Nictolis M, Branton P, Muzikansky A, Oliva E. Histopathologic prognostic factors in stage I leiomyosarcoma of the uterus: a detailed analysis of 27 cases. Am J Surg Pathol 35(4):522-9, 2011. e-Pub 2011. PMID: 21383611.
244. Mariño-Enríquez A, Wang WL, Roy A, Lopez-Terrada D, Lazar AJ, Fletcher CD, Coffin CM, Hornick JL. Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK. Am J Surg Pathol 35(1):135-44, 2011. e-Pub 2011. PMID: 21164297.
245. Powers MP, Wang WL, Hernandez VS, Patel KS, Lev DC, Lazar AJ, López-Terrada DH. Detection of myxoid liposarcoma-associated FUS-DDIT3 rearrangement variants including a newly identified breakpoint using an optimized RT-PCR assay. Mod Pathol 10(10):1307-1315, 2010. e-Pub 2010. PMID: 20581806.
246. Gupta A, Roy S, Lazar AJ, Wang WL, McAuliffe JC, Reynoso D, McMahon J, Taguchi T, Floris G, Debiec-Rychter M, Schoffski P, Trent JA, Debnath J, Rubin BP. Autophagy inhibition and antimalarials promote cell death in gastrointestinal stromal tumor (GIST). Proc Natl Acad Sci U S A 107(32):14333-14338, 2010. e-Pub 2010. PMID: 20660757.
247. Lazar AJ, Lahat G, Myers SE, Smith KD, Zou C, Wang WL, Lopez-Terrada D, Lev D. Validation of Potential Therapeutic Targets in Alveolar Soft Part Sarcoma: An Immunohistochemical Study Utilizing Tissue Microarray. Histopathology 55(6):750-755, 2009. e-Pub 2009. PMID: 20002771.
248. Wang WL, Mayordomo E, Zhang W, Hernandez VS, Tuvin D, Garcia L, Lev DC, Lazar AJ, López-Terrada D. Detection and characterization of EWSR1/ATF1 and EWSR1/CREB1 chimeric transcripts in clear cell sarcoma (melanoma of soft parts). Mod Pathol 22(9):1201-1209, 2009. e-Pub 2009. PMID: 9561568.
249. Wang WL, Mayordomo E, Zhang W, Hernandez VS, Tuvin D, Garcia L, Lev DC, Lazar AJ, Lopez-Terrada D. Detection and characterization of EWSR1/ATF1 and EWSR1/CREB1 chimeric transcripts in clear cell sarcoma (melanoma of soft parts). Mod Pathol 22(9):1201-9, 2009. e-Pub 2009. PMID: 19561568.
250. Wang WL, Farris AB, Lauwers GY, Deshpande V. Autoimmune pancreatitis-related cholecystitis: a morphologically and immunologically distinctive form of lymphoplasmacytic sclerosing cholecystitis. Histopathology 54(7):829-836, 2009. e-Pub 2009. PMID: 19635102.
251. Zou C, Smith KD, Liu J, Lahat G, Myers S, Wang WL, Zhang W, McCutcheon IE, Slopis JM, Lazar AJ, Pollock RE, Lev D. Clinical, pathological, and molecular variables predictive of malignant peripheral nerve sheath tumor outcome. Ann Surg 249(6):1014-22, 2009. e-Pub 2009. PMID: 19474676.
252. Wang WL, Hornick JL, Mallipeddi R, Zelger BG, Rother JD, Yang D, Lev DC, Trent JC, Prieto VG, Brenn T, Robson A, Calonje E, Lazar AJ. Cutaneous and subcutaneous metastases of gastrointestinal stromal tumors: A series of 5 cases with molecular analysis. Am J Dermatopathol 31(3):297-300, 2009. e-Pub 2009. PMID: 19384074.
253. Lahat G, Lazar A, Wang X, Wang WL, Zhu QS, Hunt KK, Pollock RE, Lev D. Increased VEGF-C expression is insufficient to induce lymphatic metastasis; insights from the study of human soft-tissue sarcomas. Clin Cancer Res 15(8):2637-2646, 2009. e-Pub 2009. PMID: 19351758.
254. Lawson EA, Zhang X, Crocker J, Wang WL, Klibanski A. Hypoglycemia from IGF2 overexpression associated with activiation of fetal promoters and loss of imprinting in a metastatic hemangiopericytoma. J. Clin. Endrocin. Metab 97(7):2226-2231, 2009. e-Pub 2009. PMID: 19383775.
255. Torres-Cabala CA, Wang WL, Trent J, Yana D, Chen S, Galbinicea J, Kim KB, Woodman S, Davies M, Plaza JA, Nash JW, Prieto VG, Lazar AJ, Ivan D. Correlation between KIT expression and KIT mutation in melanoma: A study of 173 cases with emphasis on acral-lentiginous/mucosal types. Mod Pathol 22(11):1446-1456, 2009. e-Pub 2009. PMID: 19718013.
256. Weaver J, Goldblum JR, Turner S, Tubbs RR, Wang WL, Lazar AJ, Rubin BP. Detection of MDM2 gene amplification or protein expression to distinguishes sclerosing mesenteritis and retroperitoneal fibrosis from inflammatory well-differentiated liposarcoma. Mod Pathol 22(1):66-70, 2009. e-Pub 2009. PMID: 18836421.
257. Lahat G, Tuvin D, Wei C, Wang WL, Pollock RE, Anaya DA, Kekele BN, Corely L, Lazar AJ, Posters PW, Lev D. Molecular prognosticators of complex karyotype soft-tissue sarcoma outcome: A tissue microarray-based study. Ann Oncol 21(5):1112-1120, 2009. e-Pub 2009. PMID: 19875755.
258. Wang WL, Patel K, Coleman N, Smith-Zagone M, Ivan D, Reed J, Lopez-Terrada D, Lazar AJ, Prieto V. COL1A1:PDGRB chimeric transcripts are not present in indetermínate fibrohistiocytic lesions of skin. Am J Dermpathol 32(2):149-153, 2009. e-Pub 2009. PMID: 19940748.
259. Wang WL, Mayordomo E, Czerniak BA, Abruzzo LV, Dal Cin P, Araujo DM, Lev DC, López-Terrada D, Lazar AJ. Fluorescence in situ hybridization (FISH) is a useful ancillary diagnostic tool for extraskeletal myxoid chondrosarcoma. Mod Pathol 21(11):1303-1310, 2008. e-Pub 2008. PMID: 18587326.
260. Wang WL, Abramson JH, Ganguly A, Rosenberg AE. The surgical pathology of notochordal remnants in adult intervertebral disks: a report of 3 cases. Am J Surg Pathol 32(8):1123-9, 2008. e-Pub 2008. PMID: 18545146.
261. McAuliffe JC, Wang WL, Pavan GM, Pricl S, Yang D, Chen SS, Lazar AJ, Pollock RE, Trent JC. Unlucky number 13? Differential effects of KIT exon 13 mutation in gastrointestinal stromal tumors. Mol Oncol 2(2):161-163, 2008. e-Pub 2008.
262. Wang WL, Abramson JH, Ganguly A, Rosenberg AE. The surgical pathology of notochordal remnants in adult intervertebral disks: A report of 3 cases. Am J Surg Pathol 32(8):1123-1129, 2008. e-Pub 2008.

Invited Articles

1. Wang WL. Prognostication in Mesenchymal Tumors: Can We Improve?. Surgical Pathology Clinics 12(1):217-225, 2019. e-Pub 2019. PMID: 30709445.
2. Al-Zaid T, Wang WL, Somaiah N, Lazar AJ. Molecular profiling of sarcomas: new vistas for precision medicine. Virchows Arch. e-Pub 2017. PMID: 28664413.
3. Wang WL, Lazar AJ. Undifferentiated "Round" Cell ("Ewing-like") Sarcoma: Not always so-round nor Ewing-like. Virchows Arch 470(4):371-372, 2017. e-Pub 2017. PMID: 28191614.

Review Articles

1. Rubino F, Alvarez-Breckenridge C, Akdemir K, Conley AP, Bishop AJ, Wang WL, Lazar AJ, Rhines LD, DeMonte F, Raza SM. Prognostic molecular biomarkers in chordomas: A systematic review and identification of clinically usable biomarker panels. Front Oncol 12:997506, 2022. e-Pub 2022. PMID: 36248987.
2. Zhang B, Ramkumar K, Cardnell RJ, Gay CM, Stewart CA, Wang WL, Fujimoto J, Wistuba II, Byers LA. A wake-up call for cancer DNA damage: the role of Schlafen 11 (SLFN11) across multiple cancers. Br J Cancer 125(10):1333-1340, 2021. e-Pub 2021. PMID: 34294893.
3. El Beaino M, Wang WL, Alaraj SF, Gugala Z, Lin PP. Osteofibrous dysplasia and adamantinoma: A summary of diagnostic challenges and surgical techniques. Surg Oncol 38:101626, 2021. e-Pub 2021. PMID: 34280695.
4. El Beaino M, Roszik J, Livingston JA, Wang WL, Lazar AJ, Amini B, Subbiah V, Lewis V, Conley AP. Mesenchymal Chondrosarcoma: a Review with Emphasis on its Fusion-Driven Biology. Curr Oncol Rep 20(5):37, 2018. e-Pub 2018. PMID: 29582189.
5. Roland CL, Wang WL, Lazar AJ, Torres KE. Myxofibrosarcoma. Surg Oncol Clin N Am 25(4):775-88, 2016. e-Pub 2016. PMID: 27591498.
6. Amini B, Kumar R, Wang WL. Soft tissue Langerhans cell histiocytosis with secondary bone involvement in extremities: evolution of lesions in two patients. Skeletal Radiol 42(9):1301-9, 2013. e-Pub 2013. PMID: 23609170.
7. Lee N, Luthra R, Lopez-Terrada D, Wang WL, Lazar AJ. Retroperitoneal undifferentiated pleomorphic sarcoma having microsatellite instability associated with Muir-Torre syndrome: case report and review of literature. J Cutan Pathol 40(8):730-3, 2013. e-Pub 2013. PMID: 23672746.
8. Ravi V, Wang WL, Lewis VO. Treatment of tenosynovial giant cell tumor and pigmented villonodular synovitis. Curr Opin Oncol 23(4):361-6, 2011. e-Pub 2011. PMID: 21577109.
9. Wang WL, Conley A, Reynoso D, Nolden L, Lazar AJ, George S, Trent JC. Mechanisms of resistance to imatinib and sunitinib in gastrointestinal stromal tumor. Cancer Chemother Pharmacol 67 Suppl 1:S15-24, 2011. e-Pub 2011. PMID: 21181476.

Other Articles

1. Nagarajan, P, Piao, J, Ning, J, Noordenbos, LE, Curry, JL, Torres Cabala, CA, Diwan, AH, Ivan, D, Aung, PP, Ross, MI, Royal, RE, Wargo, J, Wang, W, Samdani, RT, Lazar, A, Rashid, A, Davies, MA, Prieto, V, Gershenwald, JE, Tetzlaff, M Corrigendum to “Prognostic Model for Patient Survival in Primary Anorectal Mucosal Melanoma. Modern Pathology 38(8), 2025. PMID: 40541156.
2. Kumar R, Duran C, Amini B, Araujo DM, Wang WL Erratum to: Periosteal mesenchymal chondrosarcoma of the tibia with multifocal bone metastases: a case report. Skeletal Radiol 46(7):1001, 2017. PMID: 28389822.

Editorials

1. Denu RA, Yang RK, Lazar AJ, Patel SS, Lewis VO, Roszik J, Livingston JA, Wang W-L, Shaw KR, Ratan R, Zarzour MA, Bird J, Raza SM, Akdemir KC, Ahnert JR, Subbiah V, Patel S, Conley AP. Clinico-genomic profiling of conventional and dedifferentiated chondrosarcomas reveals TP53 mutation to be associated with worse outcomes. Clin Cancer Res 29(23):4844-4852, 2023. PMID: 37747813.

Abstracts

1. Lazcano, Ingram R, Lazar D, Wang A, Cloutier W, Jeffrey. TRPS1 Expression is a Marker for Malignancy in Peripheral Nerve Sheath Tumors. Bone and Soft Tissue Pathology:S54, 2023. e-Pub 2023.
2. Wangsiricharoen, Ingram S, Lazar D, Wang A, Wei-Lien. GPNMB Can Be a Useful Ancillary Tool to Identify Perivascular Epithelioid Cell Tumor (PEComa). Bone and Soft Tissue Pathology:S77, 2023. e-Pub 2023.
3. Lazcano, Rossana;Traweek, Raymond;Ingram, Wani D, Guadagnolo K, B Ashleigh;Farooqi B, Roland A, Keung C, Bishop E, Wang A, Wei-Lien;Wassif, Lazar E, Alexander. Improved Pathological Response in Undifferentiated Pleomorphic Sarcoma (UPS) Treated by Concurrent Immunotherapy and Radiation Therapy (RT) Compared with Radiation Therapy Alone. Bone and Soft Tissue Pathology:S53, 2023. e-Pub 2023.
4. Kostyuk A, Mi W, Wang WL, Guo C, Zhao J. 826 Primary Renal Sarcomas in Adult Patients: A Clinicopathologic Study of 62 Cases. USCAP 114th Annual Meeting: See the Light.
5. Denu RA, Yang RK, Lazar AJ, Patel SS, Lewis V, Roszik J, Livingston A, Wang WL, Shaw KR, Ratan R, Zarzour MA, Bird J, Raza SM, Akdemir KC, Ahnert JR, Subbiah V, Patel S, Conley AP. CLINICO-GENOMIC PROFILING OF CONVENTIONAL AND DEDIFFERENTIATED CHONDROSARCOMAS REVEALS TP53 MUTATION TO BE ASSOCIATED WITH WORSE OUTCOMES. 2023 CTOS Annual Meeting.
6. Denu RA, MD, Joseph C, Urquiola E, Byrd P, Ratan R, Zarzour MA, Conley AP, Araujo DM, Ravi V, Patel S, Wang WL, Lazar AJ, Somaiah N. CLINICO-GENOMIC ANALYSIS OF KIT/PDGFRA/SDH WILD-TYPE GASTROINTESTINAL STROMAL TUMORS IDENTIFIES POTENTIAL DRIVER MUTATIONS. 2023 CTOS Annual Meeting.
7. Livingston A, Cloutier JM, Conley AP, Gorlick R, Benjamin R, Posey K, Nassif EF, Zarzour MA, Araujo DM, Ratan R, Ravi V, Somaiah N, Lin H, Leung CH, Lazar AJ, Lewis V, Lin P, Amini B, Valenzuela RF, Patel S, Wang WL. CHEMOTHERAPY AND PROGNOSTIC SIGNIFICANCE OF EXTENT OF DEDIFFERENTIATION IN DEDIFFERENTIATED PAROSTEAL OSTEOSARCOMA. 2023 CTOS Annual Meeting.
8. Beird H, Mitra A, Liu B, McBride K, Wang WL, Ingram DR, Wani K, Keung EZ, Zarzour MA, Conley AP, Araujo DM, Livingston A, Ratan R, Patel S, Ravi V, Benjamin R, Lazar AJ, Roland C, Futreal P, Somaiah N. HISTOLOGY SPECIFIC INTRATUMORAL B-CELL BIOLOGY IN ALVEOLAR SOFT-PART SARCOMAS (ASPS) IN RESPONSE TO DURVALUMAB-TREMELIMUMAB (D-T). 2023 CTOS Annual Meeting.
9. Roszik J, Denu RA, Nassif EF, Nakazawa MS, Livingston A, Akdemir KC, Ratan R, Lazar AJ, Wang WL, Pestana R, Farooqi AS, Roland C, Keung EZ, Ravi V, Somaiah N, Patel S, Conley AP. TP53 ALTERATIONS IN SARCOMAS: AN ANALYSIS FROM THE AACR-GENIE DATABASE. 2023 CTOS Annual Meeting.
10. Amini B, Valenzuela RF, Sierra ED, Antony M, Murphy Jr WA, liu C, Green WN, Griggs M, Wang WL. ROLE OF APPARENT DIFFUSION COEFFICIENT (ADC) MAP-BASED FIRST AND HIGH-ORDER RADIOMIC FEATURES IN DISCRIMINATING SACRAL CHORDOMAS AND CHONDROSARCOMAS WITH OVERLAPPING CONVENTIONAL IMAGING FEATURES. 2023 CTOS Annual Meeting.
11. Sun B, Guerrouahen BS, Piya S, Duose D, Umzunparmak B, Reddy N, Famobio T, Veliyathu JJ, Luu S, Walters K, Meric-Bernstam F, Luthra R, Roy-Chowdhuri S, Wang WL, Wistuba II, Mantha G, Chen H. TROP2 Immunohistochemical Assay in Solid Tumors: Comparison of Interpretation Scoring Assessments by H-Score and Clinical Trials Driven ADC-Score. 2024 USCAP Annual Meeting.
12. Dehner CA, Suster DI, Molligan J, Wang WL, Gross JM, Chrisinger J. Dedifferentiated Chondrosarcoma with Low-Grade Appearing Dedifferentiated Component. 2024 USCAP Annual Meeting.
13. Guerrouahen BS, Kalhor N, Wistuba II, Parra ER, Wang WL, Mantha G, Reddy N, Famobio T, Walters K, Contreras A. Tissue-Based Multiplexing, Multispectral Immunofluorescence Testing in a CLIA-Like Laboratory Environment: a Step Forward Towards Clinical Testing. 2024 USCAP Annual Meeting.
14. Zaleski MP, Pradhan D, Jour G, Wang WL, Denai MR, Prieto VG, Torres-Cabala CA, Aung PA. Protein Kinase R-like EndoplasmReticulum Kinase (PERK) immunoexpression and Gene Expression Profile of the Tumor Microenvironment of Acral Melanoma. 2024 USCAP Annual Meeting.
15. Cuber A, Bedi D, Wang WL, Chopra S. Primary Ewing Sarcomas of the Gastrointestinal Tract: Highlighting Diagnostic Challenges and Utility of Molecular Profiling. 2024 USCAP Annual Meeting.
16. Perez A, Lazar AJ, Amini B, Wang WL. 72 Conventional Chondrosarcoma in the Pediatric Population, a Single-Institution Retrospective Review. USCAP 114th Annual Meeting: See the Light.
17. Guerrouahen B, San Lucas F, Wang WL, Roy-Chowdhuri S, Suchko M, Sun B, Patel Shah K, Reddy N, Mantha G, Meric-Bernstam F, Chen H. 1549 Optimizing TROP2 Immunohistochemistry Scoring by Automated Quantitative Image Analysis for Generating Clinical Trial-Driven IHC Scores. USCAP 114th Annual Meeting: See the Light.
18. Perez A, Cloutier Jeffrey, Lazar AJ, Wang WL. 73 Utility of GLI1 RNA In Situ hybridization in Mesenchymal Tumors: A Novel Strategy to Aid Diagnosis of an Emerging Entity. USCAP 114th Annual Meeting: See the Light.

Book Chapters

1. Wang WL, Oliveira A. Nodular Fasciitis. In: WHO Classification of Tumours of Soft Tissue and Bone. IARC, 2020.
2. Wang WL, Lazar AJ. Proliferative fasciitis / Proliferative myositis. In: WHO Classification of Tumours of Soft Tissue and Bone. IARC, 2020.
3. Wang WL, Lazar AJ. Soft Tissue Tumors. In: Oncological Pathology, 2020.
4. Wang WL, Patel R, Lazar AJ, Kutzner H. 5-3 Fibromas. In: WHO Classification of Skin Tumors, 2018.
5. Wang WL, Lazar AJ. Chapter 18: Applications of Molecular Testing to Differential Diagnosis. In: Practical Soft Tissue Pathology, 2e. 2. Elsevier, 2018.
6. Monroe MM, Guadagnolo BA, Ravi V, Wang WL, Sturgis EM. Sarcomas and Soft Tissue Tumors of the Head and Neck. In: Cancer of the Head and Neck. 5th. Wolters Kluwer, 2017.
7. Roland CL, Wang WL, Lazar AJ, Torres KE. Myxofibrosarcoma. In: Contemporary Management and Controversies of Sarcoma. 4. Elsevier, 2016.
8. Morse LJ, Wang WL, Bird J. Chordoma and Notochordal Tumors. In: Orthopaedic Knowledge Online Journal. 2, 2015.
9. Wang WL and Lazar AJ. Chapter 3. Molecular Testing in Cutaneous Mesenchymal Tumors. In: Precision Molecular Pathology of Dermatological Diseases. Springer, 2015.
10. Lazar AJF and Wang WL. Chapter 21. The Skin In:Robbins. In: Basic Pathology, 9th Ed(s). Kumar V. Sauder Elsevier, 2012.
11. Wang WL and Lazar AJ. Chapter 21. Diseases of collagen and elastic tissue. In: McKee's Pathology of the Skin 4th Ed. Calonje E, Brenn T, Lazar AJ, McKee PH. Elsevier Saunders, 2011.
12. Wang WL and Lazar AJ. Chapter 7. Lichenoid and interface dermatitis. In: McKee's Pathology of the Skin 4th Ed. Calonje E, Brenn T, Lazar AJ, McKee PH. Elsevier Saunders, 2011.
13. Al-Ibraheemi A, Pawel B, Wang WL, Rosenberg A. Fasciitis/Myositis. In: WHO Classification of Paediatric Tumours. WHO.